Lower back pain or/and sciatica

M13_LOWBACKPAINORANDSCIATICA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints M13_SCIATICA M13_LOWBACKPAIN	62397
6. Filter based on genotype QC (FinnGen only)	62397

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF4

NAME	M13_LOWBACKPAINORANDSCIATICA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_SCIATICA\|M13_LOWBACKPAIN
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lower back pain or/and sciatica based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	444753	251903	189907
Only index persons	419897	241099	178798
Unadjusted period prevalence (%)
Whole population	6.37	7.22	5.31
Only index persons	8.00	8.86	6.83
Median age at first event (years)
Whole population	50.00	51.63	47.98
Only index persons	49.49	51.03	47.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62397	38978	23419
Unadjusted period prevalence (%)	12.17	13.29	10.32
Median age at first event (years)	51.95	50.42	54.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55315: Matched controls
393029

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

8.6

323.0

4013

3555

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

323.0

3693

11360

R53

ICD-10 Finland

Malaise and fatigue

1.9

323.0

10808

43874

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.6

323.0

2897

5926

M47.82

ICD-10 Finland

Other spondylosis, cervical region

6.4

323.0

3160

3707

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.6

323.0

3275

9197

G47.3

ICD-10 Finland

Sleep apnoea

1.7

323.0

10141

44983

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

323.0

5232

19528

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

323.0

4132

12700

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

323.0

8855

31589

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

6.9

323.0

1077

1134

L84

ICPC

Back syndrome without radiat pain

3.4

323.0

2620

5692

L86

ICPC

Back syndrome with radiating pain

5.7

323.0

4796

6454

K02.1

ICD-10 Finland

Caries of dentine

1.5

323.0

29127

167357

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

323.0

21008

114273

R52.9

ICD-10 Finland

Pain, unspecified

2.5

323.0

4587

13830

N02BE01

ATC

paracetamol; systemic, rectal

3.7

323.0

49613

275997

A01

ICPC

Pain general/multiple sites

3.0

323.0

4625

11604

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

323.0

13433

47939

M79.6

ICD-10 Finland

Pain in limb

2.5

323.0

22221

82453

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

323.0

29143

166926

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

323.0

4731

15097

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

323.0

14859

56254

N03AX12

ATC

gabapentin; oral

5.2

323.0

14028

23888

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

323.0

3650

6723

R01AD09

ATC

mometasone; nasal

1.5

323.0

22645

122325

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

323.0

25621

144553

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.5

323.0

3650

10741

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

323.0

9565

42537

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

323.0

14868

71510

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

323.0

9068

41592

WX110

NOMESCO Finland

Local anesthesy

1.6

323.0

36160

211738

M54.3

ICD-10 Finland

Sciatica

20.4

323.0

8493

3463

M54.4

ICD-10 Finland

Lumbago with sciatica

16.0

323.0

23911

17851

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.1

323.0

1768

3133

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

323.0

524

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

323.0

21493

87237

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

7.1

323.0

1541

1576

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.3

323.0

1283

1277

SPAT1301

SPAT

No procedures

1.7

323.0

16155

76953

SPAT1310

SPAT

Counselling related to known health issue

1.6

323.0

15950

79780

N06AX16

ATC

venlafaxine; oral

2.4

323.0

8281

27250

C07AB07

ATC

bisoprolol; oral

1.6

323.0

21482

112589

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

8.1

323.0

953

850

ZXA00

NOMESCO Finland

Right side

1.6

323.0

12369

60019

M03BX02

ATC

tizanidine; oral

3.1

323.0

39231

174131

S18

ICPC

Laceration/cut

1.7

323.0

20834

103250

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.9

323.0

2172

3219

J01FF01

ATC

clindamycin; systemic

1.6

323.0

13221

64249

M01AH01

ATC

celecoxib; oral (coxibs)

2.3

323.0

10225

34727

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

323.0

7458

31696

L13

ICPC

Hip symptom/complaint

2.2

323.0

7816

27568

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

323.0

21678

104942

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.7

323.0

2376

3738

N06AX21

ATC

duloxetine; oral

3.9

323.0

8294

17200

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

323.0

1628

J01EA01

ATC

trimethoprim; systemic

1.6

323.0

11792

57315

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

323.0

15522

78036

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

323.0

14647

66688

B01AB05

ATC

enoxaparin; parenteral

1.5

323.0

13708

69031

R03DC03

ATC

montelukast; oral

1.8

323.0

7786

33282

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

323.0

7210

24506

A02BC05

ATC

esomeprazole; systemic

2.0

323.0

22180

99835

N06AB04

ATC

citalopram; systemic

1.8

323.0

10944

47679

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.7

323.0

6661

19206

UJF32

NOMESCO Finland

Coloscopy

1.9

323.0

13131

54435

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

323.0

2181

5091

R51.80

ICD-10 Finland

Headache

2.6

323.0

9380

28902

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

7.6

323.0

1745

1670

R4110

NOMESCO Finland

Physiotherapy

1.6

323.0

12544

60179

C03CA01

ATC

furosemide; systemic

1.6

323.0

11604

56615

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

7.8

323.0

15881

19349

C07AA05

ATC

propranolol; systemic

1.7

323.0

9388

43184

M54.6

ICD-10 Finland

Pain in thoracic spine

3.2

323.0

4352

10111

K30

ICD-10 Finland

Functional dyspepsia

2.1

323.0

5242

18717

N06AB10

ATC

escitalopram; oral

1.7

323.0

10093

46446

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

6.7

323.0

3182

3539

M79.7

ICD-10 Finland

Fibromyalgia

4.7

323.0

2326

3621

SPAT1153

SPAT

Removal of sutures

1.7

323.0

15702

74156

M01AE01

ATC

ibuprofen; systemic, rectal

2.2

323.0

48980

306669

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

323.0

37522

217176

ZXA05

NOMESCO Finland

Left side

1.6

323.0

11513

55589

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.8

323.0

1659

3178

R42

ICD-10 Finland

Dizziness and giddiness

2.0

323.0

11270

43758

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.5

323.0

9352

17082

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

323.0

4937

17446

N05CF01

ATC

zopiclone; oral

1.8

323.0

16072

74433

R05

ICPC

Cough

1.7

323.0

10910

49480

M70.6

ICD-10 Finland

Trochanteric bursitis

3.1

323.0

7353

18294

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

323.0

2019

4428

A02BC03

ATC

lansoprazole; oral

2.1

323.0

16091

64980

R06.0

ICD-10 Finland

Dyspnoea

2.1

323.0

13276

51641

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.8

323.0

9650

16486

J01MA02

ATC

ciprofloxacin; systemic

1.6

323.0

18561

96375

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

323.0

20213

105923

M54

ICD-10 Finland

Dorsalgia

3.0

323.0

7524

19901

N05BA04

ATC

oxazepam; oral

1.8

323.0

12732

56466

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

323.0

20142

92010

M01AH05

ATC

etoricoxib; oral

2.5

323.0

34869

160876

N02AX02

ATC

tramadol; systemic, rectal

3.7

323.0

30430

96933

N05CF02

ATC

zolpidem; oral

1.7

323.0

8567

37552

M01AE02

ATC

naproxen; oral, rectal

1.8

323.0

31028

161764

A02BC01

ATC

omeprazole; systemic

1.9

323.0

14314

62363

N06AA09

ATC

amitriptyline; systemic

3.3

323.0

6542

15341

H02AB06

ATC

prednisolone; systemic

1.9

323.0

25107

120864

N02AA05

ATC

oxycodone; systemic

2.6

323.0

8093

24004

R52.2

ICD-10 Finland

Other chronic pain

4.3

323.0

2196

3758

71700

ICD-8 Finland

+∞

323.0

569

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

323.0

11244

46353

M48.0

ICD-10 Finland

Spinal stenosis

5.6

323.0

10066

15057

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

323.0

18388

98312

R05

ICD-10 Finland

Cough

1.7

323.0

8878

40375

M54.5

ICD-10 Finland

Low back pain

21.0

323.0

42949

55698

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

323.0

12742

48149

M01AX17

ATC

nimesulide; oral

1.9

323.0

12476

51268

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

323.0

24087

90007

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

323.0

25291

143373

J01FA06

ATC

roxithromycin; oral

1.6

323.0

20396

104577

M03BC01

ATC

orphenadrine (citrate); systemic

3.2

323.0

17493

49504

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

323.0

8676

36767

J01DB01

ATC

cefalexin; oral

1.9

323.0

44309

266014

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

323.0

9600

39462

A02BA02

ATC

ranitidine; systemic

1.9

323.0

9698

39806

M79.1

ICD-10 Finland

Myalgia

2.3

323.0

7366

24254

J01DA01

ATC

[U] cefalexin; systemic

1.6

323.0

32473

186443

M25.5

ICD-10 Finland

Pain in joint

2.4

323.0

17349

63777

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

5.0

323.0

4801

7369

M02AA07

ATC

piroxicam; topical

1.7

323.0

17988

86739

J01FA09

ATC

clarithromycin; systemic

1.5

323.0

15316

79155

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

323.0

3101

9244

A06AD11

ATC

lactulose; oral

1.9

323.0

6435

25529

R06AE07

ATC

cetirizine; oral

1.5

323.0

21710

118813

S06.0

ICD-10 Finland

Concussion

2.0

323.0

5151

19212

P01AB01

ATC

metronidazole; oral, rectal

1.7

323.0

20500

100972

L03

ICPC

Low back symptom/complaint

3.9

323.0

19373

47234

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

323.0

27079

152048

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

323.0

20811

107982

L15

ICPC

Knee symptom/complaint

1.8

323.0

9904

43099

XA402

NOMESCO Finland

ENMG

4.0

323.0

1585

2905

SPAT1216

SPAT

Assessment of functional ability

1.9

323.0

6909

27817

R07.3

ICD-10 Finland

Other chest pain

2.2

323.0

4673

15707

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

7.9

323.0

2790

2633

L01

ICPC

Neck symptom/complaint

2.1

323.0

7226

26459

G44.2

ICD-10 Finland

Tension-type headache

2.5

323.0

7954

25131

SPAT1263

SPAT

Sampling

1.6

323.0

21937

114687

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

323.0

9340

35781

R02

ICPC

Shortness of breath/dyspnoea

2.0

323.0

5830

21753

M02AA10

ATC

ketoprofen; topical

1.8

323.0

7387

31776

L08

ICPC

Shoulder symptom/complaint

2.0

323.0

9592

37631

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

7.2

323.0

2163

2215

SPAT1260

SPAT

Consultation of another employee

1.8

323.0

8794

37989

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.0

323.0

1965

2063

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

323.0

19428

104174

L28

ICPC

Limited function/disability (L)

2.3

323.0

8110

26974

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

323.0

4274

13434

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

8.5

323.0

1372

1169

M01AX05

ATC

glucosamine; oral

1.7

323.0

8524

37483

M54.8

ICD-10 Finland

Other dorsalgia

3.7

323.0

2552

5041

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

323.0

6436

26492

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

323.0

3443

10759

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

8.8

323.0

8907

8370

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

323.0

9393

39816

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.3

323.0

1554

2125

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

323.0

4653

13916

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

323.0

16427

65326

M54.2

ICD-10 Finland

Cervicalgia

3.0

323.0

4362

10882

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

323.0

13047

62826

J02AC01

ATC

fluconazole; systemic

1.6

323.0

20038

103619

R03AC02

ATC

salbutamol; inhalant

1.9

323.0

28735

144804

M01AH02

ATC

rofecoxib; oral

2.2

323.0

6708

23196

N05BA01

ATC

diazepam; systemic, rectal

2.0

323.0

6718

25599

N05AH04

ATC

quetiapine; oral

1.9

323.0

8866

35116

L17

ICPC

Foot/toe symptom/complaint

1.9

323.0

12888

54655

A02BC02

ATC

pantoprazole; systemic

2.3

323.0

36694

180584

N03AX16

ATC

pregabalin; oral

4.5

323.0

19753

43032

N06AX11

ATC

mirtazapine; oral

2.0

323.0

17856

75025

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

323.0

9234

32141

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

323.0

14741

73852

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.6

323.0

29138

117914

M54.1

ICD-10 Finland

Radiculopathy

6.0

323.0

3181

3942

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

323.0

25459

134498

J01FA10

ATC

azithromycin; systemic

1.5

323.0

29498

171129

SPAT1312

SPAT

General health counselling

1.5

323.0

15821

82245

WZA90

NOMESCO Finland

Other doctors statement

1.6

323.0

11244

53871

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

323.0

8684

35607

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

323.0

28870

156905

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

323.0

12114

51186

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.8

323.0

9165

11183

L02

ICPC

Back symptom/complaint

2.7

323.0

5450

15425

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

323.0

17676

93565

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

323.0

14816

70669

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

323.0

4225

14613

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

323.0

32927

195554

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

323.0

6201

23160

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

323.0

5452

17196

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

323.0

9350

35632

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

6.0

323.0

4031

5103

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

323.0

11984

49366

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

323.0

15534

62501

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

323.0

4525

15335

Z71.8

ICD-10 Finland

Other specified counselling

1.6

323.0

11600

56167

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.3

323.0

1557

2141

X58

ICD-10 Finland

Exposure to other specified factors

1.8

323.0

6829

28206

M43.1

ICD-10 Finland

Spondylolisthesis

5.3

323.0

2882

4068

J01AA02

ATC

doxycycline; systemic

1.9

323.0

41559

239781

J01CA04

ATC

amoxicillin; systemic

1.5

323.0

42152

265243

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

10.5

323.0

12026

10157

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.0

323.0

5381

20261

J01CA08

ATC

pivmecillinam; oral

1.5

323.0

18838

100726

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

23055

119791

AA1AD

NOMESCO Finland

CT of head and brain

1.9

323.0

11750

48423

M01AC06

ATC

meloxicam; systemic, rectal

2.1

323.0

20311

86569

M01AB05

ATC

diclofenac; systemic, rectal

2.3

323.0

38485

193800

N30.0

ICD-10 Finland

Acute cystitis

1.8

323.0

6541

26766

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

323.0

7713

31585

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

323.0

16798

62514

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

323.0

7042

24521

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

321.9

4734

17531

N03AE01

ATC

clonazepam; systemic

2.5

321.5

2972

8886

L12

ICPC

Hand/finger symptom/complaint

1.8

318.4

6704

28214

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

318.4

19526

107416

M01AB55

ATC

diclofenac, combinations; oral

2.3

316.2

3268

10347

SPAT1254

SPAT

Administration of medicine

1.8

315.9

6914

29456

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

315.6

6369

26431

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

313.9

5679

22705

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

312.8

3675

12362

R05FB02

ATC

cough suppressants and expectorants

1.5

312.0

17359

93533

KMAK

NOMESCO Finland

1.4

311.9

26072

151956

WX290

NOMESCO Finland

Other blockade of nerve

1.4

309.9

22106

125026

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

309.4

3590

12006

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

308.6

5068

19558

M43.0

ICD-10 Finland

Spondylolysis

4.9

307.4

1123

1644

R60.0

ICD-10 Finland

Localized oedema

1.9

307.4

4895

18675

SPAT1229

SPAT

Assessment of need for aid

2.2

306.1

3601

12115

M01AB08

ATC

etodolac; oral

2.2

305.6

3629

12263

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.3

305.0

3158

10001

N03AX09

ATC

lamotrigine; oral

2.6

303.5

2588

7397

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

302.0

6648

28340

N04BC05

ATC

pramipexole; oral

2.2

301.1

3375

11102

N06AB03

ATC

fluoxetine; oral

1.8

300.8

6025

24910

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

300.6

4500

16757

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

297.4

3458

11568

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

297.3

12444

62923

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.8

295.7

1424

2731

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

293.3

2790

8458

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.1

290.0

1816

4273

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

289.8

4669

17868

R74

ICPC

Upper respiratory infection acute

1.5

288.9

13895

72355

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

288.2

9428

44881

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

287.9

3921

14044

A28

ICPC

Limited function/disability NOS

1.8

286.0

5985

25069

R96

ICPC

Asthma

2.0

285.0

4038

14697

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

284.4

4984

19658

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

283.3

6561

28364

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.9

282.4

1326

2487

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

282.2

4098

15059

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

280.9

3926

14205

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

280.8

2497

7300

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.8

280.4

1350

2588

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.4

280.2

1513

3188

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

280.1

8943

42269

R52.1

ICD-10 Finland

Chronic intractable pain

8.6

279.2

677

563

N01

ICPC

Headache

1.9

278.6

5081

20315

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

278.2

2903

9216

R5599

NOMESCO Finland

Other rehabilitation service

3.4

278.0

1507

3185

D01

ICPC

Abdominal pain/cramps general

1.8

278.0

5136

20626

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

277.1

18875

105123

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

276.9

2617

7901

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

275.8

3917

14261

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

6.9

274.7

765

793

G54.0

ICD-10 Finland

Brachial plexus disorders

3.5

274.3

1425

2911

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

273.5

11519

58140

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

272.2

4675

18294

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

272.0

4453

17122

R03BA01

ATC

beclometasone; inhalant

1.7

268.0

6471

28286

Z50.1

ICD-10 Finland

Other physical therapy

2.4

267.0

2647

8187

R03BA05

ATC

fluticasone; inhalant

1.6

265.5

8436

39759

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

265.2

6071

26110

SPAT1240

SPAT

Therapeutic discussion

1.8

264.6

5368

22222

R11

ICD-10 Finland

Nausea and vomiting

2.0

263.9

3761

13702

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.2

263.8

1599

3672

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

263.8

12033

61722

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

263.5

2831

9110

EBA00

NOMESCO Finland

Extraction of tooth

1.4

261.4

15544

84131

ACC51

NOMESCO Finland

Release of median nerve

2.1

261.2

3405

11955

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

261.1

5804

24726

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

259.4

15411

83364

M35.7

ICD-10 Finland

Hypermobility syndrome

5.2

259.1

907

1265

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

258.7

2975

9880

R03BA02

ATC

budesonide; inhalant

1.6

258.0

8072

37863

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

256.7

2335

6903

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

255.7

5108

21024

UKC02

NOMESCO Finland

Cystoscopy

1.7

255.6

6704

29977

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

255.6

2786

9022

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

254.3

2799

9105

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

253.9

18536

104071

R03AC03

ATC

terbutaline; inhalant

1.7

253.3

6529

29046

L29

ICPC

Musculoskeletal sympt/complt other

2.1

253.2

3428

12223

N02AJ13

ATC

tramadol and paracetamol; systemic

4.0

252.9

1129

2022

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

252.4

4464

17625

H02AB04

ATC

methylprednisolone; systemic

1.7

251.4

6546

29201

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

251.3

9863

48845

L16

ICPC

Ankle symptom/complaint

1.8

251.3

4620

18487

R06AX27

ATC

desloratadine; oral

1.5

251.0

12761

66841

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

250.6

6181

27146

N06AA10

ATC

nortriptyline; systemic

3.7

250.1

1216

2349

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.9

249.0

918

1357

M01AH03

ATC

valdecoxib; oral

2.2

247.8

3001

10198

A04

ICPC

Weakness/tiredness general

1.7

246.9

5912

25730

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

246.7

9208

45048

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

244.5

4884

20085

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.1

244.4

1530

3595

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

244.2

6107

26910

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

244.0

1880

5055

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

8.7

243.8

590

489

Z01.2

ICD-10 Finland

Dental examination

1.4

242.6

19494

111040

M53.2

ICD-10 Finland

Spinal instabilities

8.3

242.3

602

522

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

242.1

4077

15805

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.4

241.0

2355

7222

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

240.5

4015

15514

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

239.9

3191

11285

M01AX01

ATC

nabumetone; oral

2.5

238.5

2088

6040

Z00.0

ICD-10 Finland

General medical examination

1.6

237.9

8386

40430

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.6

237.0

576

481

C08CA01

ATC

amlodipine; oral

1.4

237.0

14478

78432

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

4.6

236.9

912

1412

D11

ICPC

Diarrhoea

1.7

236.2

5265

22404

R01AD12

ATC

fluticasone furoate; nasal

1.4

233.6

13933

75093

SPAT1283

SPAT

Restricted health certificate

1.5

233.6

8775

42927

J20

ICD-10 Finland

Acute bronchitis

1.8

233.5

4289

17134

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

232.6

5944

26327

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

5.0

232.1

834

1198

TAB20

NOMESCO Finland

Epidural puncture

7.3

232.0

626

619

D07AC01

ATC

betamethasone; topical

1.4

230.1

15399

84728

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.5

229.7

1198

2453

S29

ICPC

Skin symptom/complaint other

1.6

229.6

7298

34265

C10AA07

ATC

rosuvastatin; oral

1.5

229.2

9788

49260

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

229.2

8481

41320

J45

ICD-10 Finland

Asthma

1.8

228.7

4380

17741

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

228.0

2626

8716

P03

ICPC

Feeling depressed

1.8

227.8

4393

17833

R21

ICPC

Throat symptom/complaint

1.5

226.4

9487

47532

E66.8

ICD-10 Finland

Other obesity

2.2

226.3

2524

8252

C10AA05

ATC

atorvastatin; oral

1.4

226.2

15450

85260

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.3

225.6

1279

2795

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

225.1

6985

32578

N17

ICPC

Vertigo/dizziness

1.8

223.2

4697

19610

H01

ICPC

Ear pain/earache

1.7

222.9

4878

20614

U02

ICPC

Urinary frequency/urgency

1.7

222.8

5657

24989

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

222.7

6275

28528

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

222.2

1537

3860

N02AC04

ATC

dextropropoxyphene; oral

2.7

221.7

1709

4592

D06

ICPC

Abdominal pain localized other

1.9

221.6

3729

14433

N06AB06

ATC

sertraline; oral

1.7

219.7

5072

21784

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

219.6

10967

56966

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

218.8

5502

24229

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

218.2

7748

37336

N05CD07

ATC

temazepam; oral

1.7

216.8

5106

22055

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

5.0

216.4

777

1115

WX002

NOMESCO Finland

Sedation and analgesia

1.5

216.0

8445

41605

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

215.7

3218

11901

R01AD08

ATC

fluticasone; nasal

1.4

215.1

13122

70802

P06

ICPC

Sleep disturbance

1.8

215.0

4458

18512

A02BC04

ATC

rabeprazole; oral

1.9

214.4

3798

14963

A02BA04

ATC

nizatidine; systemic

1.9

212.9

3350

12641

SPAT1058

SPAT

PEF monitoring instruction

1.9

211.7

3648

14229

L14

ICPC

Leg/thigh symptom/complaint

2.0

211.5

3191

11850

A98

ICPC

Health maint/preventive medicine

1.7

211.4

51442

349155

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

211.4

4932

21235

SGA01

NOMESCO Finland

Tooth opening as first aid

1.6

211.1

7355

35250

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

211.0

3445

13180

W19

ICD-10 Finland

Unspecified fall

1.8

210.9

4125

16803

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

10.2

210.5

465

326

A03FA02

ATC

cisapride; oral, rectal

1.9

210.5

3330

12591

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

209.2

4132

16883

C10AA01

ATC

simvastatin; oral

1.4

209.1

17247

97971

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

209.1

4011

16231

R09

ICPC

Sinus symptom/complaint

1.9

209.0

3585

13959

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

208.9

3316

12551

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.6

208.9

818

1289

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

208.3

8657

43189

A11

ICPC

Chest pain NOS

2.0

206.2

3162

11811

S80.0

ICD-10 Finland

Contusion of knee

2.0

205.8

2985

10912

S22.3

ICD-10 Finland

Fracture of rib

2.0

205.7

2835

10155

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

205.6

1862

5481

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.5

204.4

1851

5446

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

204.4

2034

6285

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.3

203.9

2101

6606

R50.9

ICD-10 Finland

Fever, unspecified

1.6

203.3

6134

28338

G04BD12

ATC

mirabegron; oral

1.8

201.4

3982

16268

C09CA06

ATC

candesartan; oral

1.5

200.6

9081

46101

J05AB01

ATC

aciclovir; systemic

1.5

200.5

9251

47149

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.7

200.1

1571

4264

E0000UV

ATC

1.3

200.1

18096

104127

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.9

200.1

3488

13650

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

199.4

1908

5779

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

199.3

3219

12257

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.3

199.0

1109

2391

M01AC01

ATC

piroxicam; systemic, rectal

1.6

198.3

5701

25999

R51

ICD-10 Finland

Headache

2.1

198.1

2462

8439

R13

ICD-10 Finland

Dysphagia

2.0

198.1

2717

9709

H02AB07

ATC

prednisone; oral

1.6

198.0

6130

28493

H03AA01

ATC

levothyroxine sodium; systemic

1.4

196.9

10047

52238

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

196.9

4222

17693

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

196.8

7026

33817

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

196.4

11757

63021

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

194.9

12579

68336

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

194.8

5005

22128

R55

ICD-10 Finland

Syncope and collapse

1.7

194.7

4463

19087

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

194.0

1750

5136

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.1

193.4

2449

8461

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

193.4

3716

15031

A03

ICPC

Fever

1.5

193.0

7326

35750

SPAT1097

SPAT

Recording of ECG

1.6

192.5

6086

28424

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.3

192.5

2078

6679

K59.0

ICD-10 Finland

Constipation

2.1

191.5

2363

8073

D19

ICPC

Teeth/gum symptom/complaint

1.4

191.4

11818

63652

P76

ICPC

Depressive disorder

2.0

190.8

2928

10931

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

190.3

3041

11527

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.3

190.3

2041

6540

J46

ICD-10 Finland

Status asthmaticus

2.9

190.3

1316

3303

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

189.7

5193

23351

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

189.3

12435

67696

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

189.3

3884

16043

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.0

188.8

2681

9709

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

188.8

9504

49224

A29

ICPC

General symptom/complaint other

1.7

188.0

4671

20444

SFA00

NOMESCO Finland

Small filling

1.6

187.9

5702

26344

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

187.9

4067

17083

N06AX03

ATC

mianserin; oral

2.2

187.2

2144

7083

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

186.8

4122

17415

N05BA12

ATC

alprazolam; oral

1.7

186.1

4467

19351

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

186.1

5037

22572

-1

NOMESCO Finland

1.4

185.9

15678

88945

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

185.0

3193

12441

J01MA12

ATC

levofloxacin; systemic

1.5

184.8

7714

38409

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.2

183.5

1074

2402

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

183.0

3404

13610

R03BB04

ATC

tiotropium bromide; inhalant

1.8

182.9

3919

16403

R35

ICD-10 Finland

Polyuria

2.0

182.8

2614

9488

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

182.4

1606

4650

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

182.3

8564

43703

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

181.8

2359

8230

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

181.5

6677

32307

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

181.0

8984

46350

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

180.7

3352

13384

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

180.7

12460

68310

M77.4

ICD-10 Finland

Metatarsalgia

2.1

180.4

2387

8396

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

179.9

4751

21139

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

179.3

3605

14781

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

7.6

179.2

469

443

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

179.2

2688

9940

K07.60

ICD-10 Finland

Snapping jaw

2.1

178.9

2290

7943

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

178.4

2614

9578

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

177.1

2966

11427

M70.7

ICD-10 Finland

Other bursitis of hip

3.0

177.0

1127

2676

K08.80

ICD-10 Finland

Toothache NOS

1.8

176.5

3550

14557

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

174.9

34328

218986

ZXA10

NOMESCO Finland

Bilateral

1.5

174.3

7731

38948

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

173.9

3171

12582

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

172.5

3030

11870

R52.0

ICD-10 Finland

Acute pain

2.5

172.0

1471

4192

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.1

171.9

2290

8075

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

7.1

171.9

470

475

C05AA08

ATC

fluocortolone; rectal, topical

1.5

171.6

6062

29023

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

11.6

171.2

355

219

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

171.1

2089

7097

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

170.6

3280

13247

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

170.1

4687

21075

WX308

NOMESCO Finland

Sacral anesthesy

13.9

170.0

326

168

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

169.6

2759

10513

N03AF01

ATC

carbamazepine; oral, rectal

2.1

169.5

2218

7761

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.8

169.4

1228

3174

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

168.7

5270

24480

G83.4

ICD-10 Finland

Cauda equina syndrome

12.4

167.7

337

194

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

167.7

2008

6764

R12

ICD-10 Finland

Heartburn

1.8

167.3

3020

11938

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

167.1

4560

20446

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

166.5

2642

9975

N06AA12

ATC

doxepin; systemic

2.0

166.2

2249

7979

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.2

166.0

965

2147

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

165.8

2863

11143

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

165.4

2170

7599

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

165.4

2942

11571

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

6.3

165.3

489

553

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

165.2

5794

27675

C07AB02

ATC

metoprolol; systemic

1.4

164.7

8062

41384

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

164.7

8754

45664

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

164.7

1979

6674

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

164.6

4855

22214

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

164.0

2760

10644

SPAT1211

SPAT

Application of soft bandage

1.7

163.4

3851

16562

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

3.7

163.2

811

1595

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

163.1

4356

19410

R00.2

ICD-10 Finland

Palpitations

1.8

163.0

3039

12144

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

162.9

3507

14676

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

162.9

1153

2934

A01AB09

ATC

miconazole; local oral

1.7

162.6

3659

15522

M01AE52

ATC

naproxen and esomeprazole; oral

2.4

162.1

1496

4442

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

161.8

4700

21415

P01

ICPC

Feeling anxious/nervous/tense

1.6

161.8

4716

21509

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

161.4

3666

15596

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

161.2

2650

10129

D02

ICPC

Abdominal pain epigastric

1.9

161.1

2475

9229

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

160.6

3130

12689

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

9.1

159.9

375

295

N06AX12

ATC

bupropion; oral

1.9

158.8

2791

10927

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

158.3

3707

15907

K04.0

ICD-10 Finland

Pulpitis

1.6

157.9

4367

19635

C01DA14

ATC

isosorbide mononitrate; oral

1.5

157.8

5434

25822

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

6.3

157.7

467

529

T90

ICPC

Diabetes non-insulin dependent

1.4

157.6

8901

46914

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.3

157.4

886

1924

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

156.9

2063

7230

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

7.7

156.7

404

373

L05

ICPC

Flank/axilla symptom/complaint

2.0

156.5

2277

8310

B01AC04

ATC

clopidogrel; oral

1.5

156.1

5716

27547

9211

FHL

Exploration or removal of diskusprolapse

3.0

155.6

996

2373

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

155.5

3303

13760

M05BA04

ATC

alendronic acid; oral

1.8

155.1

3012

12192

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

154.9

7086

35834

C09CA01

ATC

losartan; oral

1.4

154.7

9377

50040

A46

ICD-10 Finland

Erysipelas

1.5

154.7

5482

26216

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

154.5

2414

9054

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

152.5

3176

13147

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.8

152.4

731

1395

C10AX09

ATC

ezetimibe; oral

1.6

152.0

4113

18375

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

7.1

151.2

411

412

XQ800

NOMESCO Finland

Prick test

1.7

150.9

3289

13803

L11

ICPC

Wrist symptom/complaint

1.7

150.8

3342

14098

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

150.8

7469

38355

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

150.1

3755

16413

N06AX26

ATC

vortioxetine; oral

1.9

149.8

2497

9589

SPAT1252

SPAT

Overall medication plan or its review

1.8

149.5

2757

10966

XKD00

NOMESCO Finland

Uroflowmetry

1.5

149.4

5909

28958

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

148.3

14534

83690

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

147.9

9975

54172

R03BA08

ATC

ciclesonide; inhalant

1.7

147.9

3446

14755

J01MA14

ATC

moxifloxacin; systemic

1.7

147.5

3628

15776

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

147.3

2955

12083

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

147.2

2968

12155

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.0

147.2

654

1166

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

147.1

2971

12174

R07.0

ICD-10 Finland

Pain in throat

1.8

146.5

2674

10595

L18

ICPC

Muscle pain

2.2

146.3

1627

5295

NA3BG

SPAT

2.9

145.9

985

2432

D07AD01

ATC

clobetasol; topical

1.5

145.9

6365

31837

R06.5

ICD-10 Finland

Mouth breathing

1.7

145.5

3610

15738

JAH01

NOMESCO Finland

Laparoscopy

2.0

145.0

1968

6984

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

145.0

4781

22452

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.0

144.9

642

1142

H57.1

ICD-10 Finland

Ocular pain

2.3

144.1

1429

4399

XF402

NOMESCO Finland

ECG with work load test

1.6

143.4

4299

19713

D82

ICPC

Teeth/gum disease

1.3

143.3

15661

91471

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

143.2

5314

25655

B02AA02

ATC

tranexamic acid; systemic

1.5

142.5

6053

30096

M45

ICD-10 Finland

Ankylosing spondylitis

2.8

142.5

1048

2733

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

142.3

3881

17361

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

7.1

142.3

386

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

142.2

2581

10206

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

142.2

8747

46712

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

142.1

4411

20405

J01FA15

ATC

telithromycin; oral

1.6

141.7

4291

19724

L09

ICPC

Arm symptom/complaint

2.1

141.7

1822

6322

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

141.4

1358

4114

R25.2

ICD-10 Finland

Cramp and spasm

2.8

141.4

1023

2641

P01BA02

ATC

hydroxychloroquine; oral

1.7

141.1

3363

14486

R06AX22

ATC

ebastine; oral

1.4

141.0

7388

38303

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

140.9

4607

21585

SPAT1325

SPAT

Vaccination

1.3

140.9

14440

83542

N39.3

ICD-10 Finland

Stress incontinence

1.8

140.9

2769

11242

L04

ICPC

Chest symptom/complaint

1.9

140.6

2354

9050

R01AD01

ATC

beclometasone; nasal

1.5

140.2

6533

33100

K04.08

ICD-10 Finland

Other specified pulpit

1.8

139.4

2871

11831

G04BD08

ATC

solifenacin; oral

1.8

139.2

2539

10055

F34.1

ICD-10 Finland

Dysthymia

2.2

139.1

1578

5180

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

138.8

2511

9916

R4120

NOMESCO Finland

Occupational therapy

1.8

138.5

2603

10411

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

138.0

11199

62559

N07BA03

ATC

varenicline; oral

1.9

137.7

2231

8472

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

137.5

3833

17240

M75.8

ICD-10 Finland

Other shoulder lesions

2.2

137.4

1486

4771

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

137.3

2007

7333

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

136.9

3919

17747

M15

ICD-10 Finland

Polyarthrosis

2.1

136.7

1768

6148

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

136.1

1889

6762

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

3.9

135.5

620

1136

TAB00

NOMESCO Finland

Lumbar puncture

2.0

135.1

1895

6812

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

135.0

4165

19226

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

134.8

1692

5809

R15

ICD-10 Finland

Faecal incontinence

2.7

134.4

1055

2860

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

4.0

134.2

597

1066

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

134.2

6737

34615

U01

ICPC

Dysuria/painful urination

1.7

133.8

3032

12860

S21

ICPC

Skin texture symptom/complaint

1.5

133.4

4959

23924

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

133.2

1384

4359

J01MA06

ATC

norfloxacin; oral

1.5

133.0

5462

26933

I20.09

ICD-10 Finland

Unstable angina

1.9

133.0

2080

7796

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

132.7

4621

21959

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

132.6

4935

23814

M76.0

ICD-10 Finland

Gluteal tendinitis

3.2

132.5

788

1782

N06AX05

ATC

trazodone; oral

2.5

132.5

1143

3271

N03AG01

ATC

valproic acid; systemic, rectal

1.8

132.0

2575

10423

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

131.5

6237

31677

S20.2

ICD-10 Finland

Contusion of thorax

2.0

131.4

1990

7370

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

9.3

130.9

302

231

SPAT1210

SPAT

Application of cast or individual aid

2.0

130.7

1803

6436

H92.0

ICD-10 Finland

Otalgia

1.9

130.5

2135

8136

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

10.4

130.2

284

195

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

129.7

2704

11178

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

129.6

2247

8740

AN1

Coronary angiography

1.6

129.0

4228

19798

M19.8

ICD-10 Finland

Other specified arthrosis

2.3

128.5

1329

4176

Z30.2

ICD-10 Finland

Sterilization

1.6

128.4

4241

19893

M03BX01

ATC

baclofen; systemic

3.1

128.3

796

1856

A07AA02

ATC

nystatin; oral

1.8

127.8

2429

9747

N05AA02

ATC

levomepromazine; systemic

2.0

127.5

1755

6259

N06AB05

ATC

paroxetine; oral

1.8

127.5

2611

10732

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

127.1

2160

8340

SPAT1360

SPAT

Extensive global examination

1.7

127.0

3017

12972

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

126.8

3248

14264

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

126.8

2237

8753

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

126.6

3543

15937

M05BX04

ATC

denosumab; parenteral

2.0

126.3

1767

6341

P20

ICPC

Memory disturbance

1.6

126.2

4013

18646

RF210

NOMESCO Finland

2.3

125.8

1257

3883

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

125.4

16188

96243

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

124.8

2739

11500

WX704

NOMESCO Finland

Intubation

1.7

124.1

2928

12561

Z00.8

ICD-10 Finland

Other general examinations

1.7

124.1

2961

12746

R51.81

ICD-10 Finland

Facial pain NOS

2.6

123.9

991

2716

S70.0

ICD-10 Finland

Contusion of hip

2.2

123.6

1378

4487

M89.0

ICD-10 Finland

Algoneurodystrophy

4.5

123.4

484

765

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

123.1

2219

8746

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

123.1

1795

6549

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

123.0

2039

7804

A10BA02

ATC

metformin; oral

1.3

123.0

10684

60129

R33

ICD-10 Finland

Retention of urine

1.7

123.0

2752

11622

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

123.0

5282

26263

T82

ICPC

Obesity

2.1

122.9

1566

5408

ICD-10 Finland

2.5

122.9

1045

2965

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

122.9

1119

3295

J01

ICD-10 Finland

Acute sinusitis

1.9

122.2

2052

7889

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

122.1

9448

52238

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

122.0

572

1071

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

121.7

2718

11468

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

121.6

9531

52795

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

121.5

2295

9185

R29

ICPC

Respiratory symptom/complaint other

1.7

121.0

2562

10640

C08CA13

ATC

lercanidipine; oral

1.5

120.5

4748

23174

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

120.4

1911

7196

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

120.4

2056

7952

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

120.2

1827

6773

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

120.1

3032

13257

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

119.6

2369

9629

H02BX01

ATC

methylprednisolone, combinations; systemic

1.9

119.5

2004

7701

SPAT1262

SPAT

Handing over of treatment supplies

1.4

119.3

7192

38141

XKC03

NOMESCO Finland

Water cystometry

2.3

119.2

1248

3944

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.8

119.2

871

2262

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.4

119.0

1140

3448

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

118.5

7628

40908

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

118.2

2205

8790

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

118.2

1627

5802

K85

ICPC

Elevated blood pressure

1.5

117.7

5388

27125

A05

ICPC

Feeling ill

1.7

117.7

2545

10635

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

116.9

7246

38600

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.3

116.9

1173

3632

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

116.8

1379

4606

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.7

116.7

896

2398

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.7

116.5

570

1108

N03AX11

ATC

topiramate; oral

2.4

116.3

1121

3401

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

116.1

1494

5181

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

115.6

2550

10717

R10.0

ICD-10 Finland

Acute abdomen

2.2

115.5

1344

4461

A99

ICPC

Disease/condition unspecnature/site

1.6

115.3

3091

13732

M77.0

ICD-10 Finland

Medial epicondylitis

2.5

114.7

1032

3020

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

114.7

22850

142527

U07

ICPC

Urine symptom/complaint other

1.8

114.4

2188

8792

H29

ICPC

Ear symptom/complaint other

1.5

114.2

3857

18163

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.1

114.2

1401

4759

N81.6

ICD-10 Finland

Rectocele

1.8

113.9

2298

9396

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.5

113.8

958

2704

M01AB51

ATC

indometacin, combinations; oral, rectal

2.5

113.4

1009

2935

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.0

113.1

1590

5718

U05

ICPC

Urination problems other

2.0

112.9

1691

6231

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

112.6

1771

6645

R03AC13

ATC

formoterol; inhalant

1.9

112.6

1945

7551

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

112.6

2254

9192

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

112.0

2341

9678

R4110

SPAT

2.3

111.5

1150

3608

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

111.4

1387

4743

L60.0

ICD-10 Finland

Ingrowing nail

1.9

111.1

1724

6437

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

111.0

4170

20120

WX320

NOMESCO Finland

Spinalanesthesy

1.3

111.0

9102

50673

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.8

110.8

772

1947

D12

ICPC

Constipation

2.2

110.5

1271

4197

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

110.4

929

2620

M23.8

ICD-10 Finland

Other internal derangements of knee

2.0

110.3

1520

5421

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

9.1

110.2

257

201

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.5

110.1

962

2772

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

110.0

5971

31035

SPAT1202

SPAT

Intra-articular injection

2.2

109.7

1248

4100

UJD02

NOMESCO Finland

Gastroscopy

1.9

109.5

1865

7202

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.9

109.3

723

1761

D07AC13

ATC

mometasone; topical

1.3

109.2

12231

71117

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

109.1

1706

6389

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

109.1

2905

12878

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

108.3

1324

4492

G04CA02

ATC

tamsulosin; oral

1.3

108.3

7886

43088

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

108.1

1422

4975

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.7

108.0

2516

10743

SPAT1234

SPAT

Support of social functional capacity

1.8

107.1

1893

7405

M75.5

ICD-10 Finland

Bursitis of shoulder

2.5

107.1

930

2671

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

106.9

13561

80074

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

106.7

2760

12136

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

106.7

4296

21033

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

106.6

4148

20157

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

106.5

2181

8955

UJH02

NOMESCO Finland

Anoscopy

1.9

106.5

1664

6228

J01DA06

ATC

[U] cefuroxime; systemic

1.4

106.3

6047

31681

P29

ICPC

Psychological sympt/compl other

1.7

106.2

2407

10193

WX402

NOMESCO Finland

General anaesthesia

1.4

106.2

6725

35899

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.3

106.1

8465

46894

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.1

105.9

1369

4756

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

105.7

1545

5639

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

105.6

1486

5345

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.6

105.2

827

2245

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

105.2

3730

17753

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

3.3

105.1

595

1299

SPAT1053

SPAT

Memory test

1.4

104.9

4901

24735

G03DB01

ATC

dydrogesterone; oral

1.4

104.9

5163

26326

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.6

104.6

2961

13338

J02AC02

ATC

itraconazole; systemic

1.4

103.9

7265

39406

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

103.9

2810

12504

M01AE51

ATC

ibuprofen, combinations; systemic

2.9

103.7

713

1782

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.6

103.6

847

2352

U04

ICPC

Incontinence urine

1.9

103.6

1619

6059

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

103.4

1584

5884

SPAT1255

SPAT

Intravenous administration of medicine

1.7

103.4

2546

11043

R30.0

ICD-10 Finland

Dysuria

2.0

103.1

1431

5116

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.6

103.1

810

2198

M01AB01

ATC

indometacin; systemic, rectal

1.6

103.0

2815

12560

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

102.7

1498

5464

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

102.5

8292

45998

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

102.5

12114

70819

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

102.2

1984

8004

R01AD11

ATC

triamcinolone; nasal

1.5

102.2

3591

17054

C01CA24

ATC

epinephrine; parenteral

1.7

102.0

2508

10870

A02BX02

ATC

sucralfate; oral

1.9

101.8

1557

5780

G03DC02

ATC

norethisterone; oral

1.5

101.8

3935

19088

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

101.6

10037

57290

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

101.4

2299

9732

R75

ICPC

Sinusitis acute/chronic

1.8

101.3

1844

7283

ZZH40

NOMESCO Finland

Substitute of bone

3.8

101.2

478

902

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

101.0

1321

4612

M75.2

ICD-10 Finland

Bicipital tendinitis

2.4

100.7

972

2951

SPAT1101

SPAT

Orthostatic test

1.9

100.7

1556

5800

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.4

100.6

935

2784

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.1

100.2

627

1470

TAC99

NOMESCO Finland

Other blockade for chronic pain

4.8

100.2

368

544

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

2.6

99.9

823

2296

WZC30

NOMESCO Finland

Teaching

1.4

99.8

5081

26059

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.8

99.8

1876

7490

M22.4

ICD-10 Finland

Chondromalacia patellae

2.0

99.7

1324

4649

F29

ICPC

Eye symptom/complaint other

1.6

99.7

3144

14547

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

99.3

1227

4182

S01

ICPC

Pain/tenderness of skin

1.9

99.3

1644

6284

H13

ICPC

Plugged feeling ear

1.4

99.2

6668

35913

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.2

99.2

1149

3805

R06.2

ICD-10 Finland

Wheezing

1.9

99.0

1706

6614

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

98.9

2264

9612

M48.9

ICD-10 Finland

Spondylopathy, unspecified

5.9

98.8

307

372

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.0

98.8

1387

4980

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.1

98.8

1182

3971

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.6

98.6

2882

13083

SPAT1285

SPAT

Provision of consultation response

1.7

98.3

2100

8732

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

7.3

98.2

261

254

G01AA10

ATC

clindamycin; vaginal

1.4

98.2

5815

30646

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

97.9

5561

29096

F32

ICD-10 Finland

Depressive episode

1.7

97.9

2169

9121

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

97.8

3259

15281

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.2

97.7

1155

3859

N06AX22

ATC

agomelatine; oral

2.4

97.5

926

2788

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.1

97.4

1193

4050

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.1

97.1

1153

3861

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

97.0

1895

7661

SPAT1104

SPAT

Monitoring of emergency patient

1.6

97.0

2547

11241

G50.1

ICD-10 Finland

Atypical facial pain

2.7

96.9

737

1962

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

96.8

2072

8621

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

96.5

2409

10482

M76.6

ICD-10 Finland

Achilles tendinitis

1.8

96.1

1751

6916

NA3AA

SPAT

2.5

96.0

823

2346

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

95.9

3841

18764

C10AC01

ATC

colestyramine; oral

2.2

95.9

1049

3385

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

95.6

3630

17530

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.6

95.6

479

951

H02.3

ICD-10 Finland

Blepharochalasis

1.7

95.6

2152

9091

R06AE09

ATC

levocetirizine; oral

1.4

95.5

6003

31954

M25.2

ICD-10 Finland

Flail joint

3.1

95.4

582

1343

K80

ICPC

Cardiac arrhythmia NOS

1.6

94.9

2658

11931

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

94.9

2913

13384

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

94.6

1387

5068

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

5.0

94.6

339

488

M46.4

ICD-10 Finland

Discitis, unspecified

7.0

94.3

257

260

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.2

94.2

1035

3346

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

93.6

8207

45998

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

93.6

2397

10505

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.6

93.2

743

2034

J01FA01

ATC

erythromycin; systemic

1.4

92.7

6021

32212

XF404

NOMESCO Finland

Ambulatory ECG

1.5

92.5

3424

16434

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

92.5

2954

13704

A06AC51

ATC

ispaghula, combinations; systemic

1.8

92.3

1884

7722

L20

ICPC

Joint symptom/complaint NOS

2.0

92.3

1363

4993

J45.8

ICD-10 Finland

Mixed asthma

2.1

92.2

1187

4114

1220

FHL

Arthroscopy

1.9

92.2

1552

5965

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.5

92.0

783

2225

L10

ICPC

Elbow symptom/complaint

1.8

92.0

1769

7115

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

91.9

3198

15138

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

91.9

10404

60347

G01AF05

ATC

econazole; vaginal

1.6

91.7

2968

13809

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

91.5

2827

13008

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

91.5

1502

5723

A01AB04

ATC

amphotericin B; local oral

1.8

91.4

1746

7007

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

91.4

1930

7995

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

91.0

2467

10975

B01AA03

ATC

warfarin; systemic

1.3

90.8

6956

38197

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

90.4

2529

11346

R25.1

ICD-10 Finland

Tremor, unspecified

2.1

90.2

1064

3553

R06AX13

ATC

loratadine; oral

1.4

90.2

6360

34472

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

89.9

1629

6421

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.8

89.6

426

809

SPAT1106

SPAT

Acupuncture

4.1

89.5

389

682

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

89.5

1100

3741

L95

ICPC

Osteoporosis

2.2

89.4

1009

3303

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.1

89.4

270

316

N02CC03

ATC

zolmitriptan; nasal, oral

1.7

89.4

2143

9215

E000001

ATC

1.3

89.1

8564

48581

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

89.1

1761

7143

F61.0

ICD-10 Finland

Mixed personality disorders

2.5

89.0

776

2235

N06AG02

ATC

moclobemide; oral

1.8

88.9

1695

6795

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.0

88.9

1268

4584

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

88.8

2215

9633

K04.09

ICD-10 Finland

Pulpit UNS

1.8

88.8

1654

6581

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

88.8

1326

4877

S97

ICPC

Chronic ulcer skin

1.7

88.7

1887

7833

C08DA01

ATC

verapamil; systemic

1.9

88.7

1507

5812

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.9

88.5

1380

5157

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

88.3

1881

7812

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

88.3

4387

22368

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

2.9

88.2

601

1495

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

87.8

1772

7236

N76.0

ICD-10 Finland

Acute vaginitis

1.6

87.7

2255

9886

K07

ICPC

Swollen ankles/oedema

1.9

87.7

1461

5595

U71

ICPC

Cystitis/urinary infection other

1.6

87.4

2255

9900

H02

ICPC

Hearing complaint

1.4

87.1

4109

20741

D10

ICPC

Vomiting

1.6

87.1

2374

10576

Z08

ICPC

Social welfare problem

3.0

87.0

559

1337

N30

ICD-10 Finland

Cystitis

1.6

86.8

2848

13288

NF1DA

NOMESCO Finland

X-ray of hips

2.4

86.8

838

2544

G43.3

ICD-10 Finland

Complicated migraine

2.6

86.8

692

1894

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

86.6

2607

11913

R03AC12

ATC

salmeterol; inhalant

1.8

86.6

1642

6571

OAA65

SPAT

1.5

86.6

3866

19301

M75

ICD-10 Finland

Shoulder lesions

1.8

86.4

1597

6338

N62

ICD-10 Finland

Hypertrophy of breast

1.8

86.3

1556

6124

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

86.3

3291

15892

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.0

86.3

1190

4244

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

86.1

1006

3343

G01AF01

ATC

metronidazole; vaginal

1.5

86.1

3464

16923

SPAT1324

SPAT

Screening procedure

1.3

86.1

7040

39009

A02BA03

ATC

famotidine; systemic

1.9

86.0

1410

5366

B01AF01

ATC

rivaroxaban; oral

1.4

86.0

4031

20320

R06.4

ICD-10 Finland

Hyperventilation

2.5

85.9

734

2090

L92

ICPC

Shoulder syndrome

2.3

85.8

877

2740

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

1.7

85.6

1942

8217

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

85.4

2038

8752

D09

ICPC

Nausea

1.8

84.9

1693

6886

J05AB11

ATC

valaciclovir; oral

1.4

84.9

5069

26710

A08

ICPC

Swelling

1.9

84.9

1467

5691

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.6

84.9

2299

10224

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

7.0

84.8

233

239

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

84.6

1330

4986

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

1.6

84.4

2721

12644

N07BB01

ATC

disulfiram; oral

1.8

84.3

1741

7160

G04BD07

ATC

tolterodine; oral

1.8

84.2

1742

7167

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

3.4

84.2

447

931

R07

ICPC

Sneezing/nasal congestion

1.6

84.0

2587

11887

N89

ICPC

Migraine

1.9

84.0

1296

4827

SPAT1059

SPAT

Spirometry at the office

1.7

84.0

1923

8160

N06AA06

ATC

trimipramine; systemic

2.2

84.0

979

3252

C03AA03

ATC

hydrochlorothiazide; oral

1.5

83.6

3305

16080

1410

FHL

Laparoscopy

2.1

83.4

1026

3490

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

83.3

1418

5471

F01

ICPC

Eye pain

2.1

83.2

1075

3732

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

83.2

3459

17012

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.5

83.0

732

2121

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.6

83.0

691

1939

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

82.8

3522

17405

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

82.4

2939

13981

R31

ICD-10 Finland

Unspecified haematuria

1.5

82.3

3418

16805

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

82.2

772

2312

C08CA05

ATC

nifedipine; systemic

1.6

82.2

2310

10369

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

2.6

81.9

659

1815

S15

ICPC

Foreign body in skin

1.6

81.8

2246

10019

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.3

81.5

813

2508

T74.1

ICD-10 Finland

Physical abuse

2.3

81.4

796

2433

-50

ICPC

Medication/prescr/renewal

1.8

81.4

1581

6378

M67.4

ICD-10 Finland

Ganglion

1.6

81.0

2409

10969

A97

ICPC

No disease

1.3

80.9

5810

31540

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

80.9

1350

5174

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.9

80.7

556

1392

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.9

80.6

1325

5049

L99

ICPC

Musculoskeletal disease other

2.4

80.5

742

2201

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.0

80.5

512

1217

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

80.4

976

3300

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

80.4

1103

3925

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

6.0

80.3

245

291

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

3.8

80.3

372

692

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

8.0

80.2

201

179

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.9

80.2

1355

5213

K08.3

ICD-10 Finland

Retained dental root

1.6

80.0

2541

11758

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.9

80.0

1292

4891

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

22.4

80.0

129

M65.3

ICD-10 Finland

Trigger finger

1.8

79.8

1556

6285

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

8.3

79.7

196

169

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

4.6

79.7

304

469

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

79.6

2928

14020

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.9

79.5

1210

4483

C10AA04

ATC

fluvastatin; oral

1.5

79.2

2895

13845

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

79.2

3420

16948

M05BA07

ATC

risedronic acid; oral

2.0

79.1

1066

3765

S04

ICPC

Lump/swelling localized

1.5

79.1

3504

17453

K04

ICPC

Palpitations/awareness of heart

1.7

79.1

1833

7802

SPAT1284

SPAT

Extensive health certificate

1.9

79.0

1188

4381

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

2.3

79.0

783

2410

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

78.8

9966

58438

P25

ICPC

Phase of life problem adult

1.8

78.7

1592

6505

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

78.7

1581

6447

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.7

78.4

1852

7927

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

78.4

1071

3806

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

78.2

4621

24284

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.5

78.2

2634

12360

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.4

78.1

3773

19114

NBG10

NOMESCO Finland

Acromioplastia

2.1

78.1

957

3250

N02CC04

ATC

rizatriptan; oral

1.6

78.0

2243

10125

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

77.9

1187

4399

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.2

77.8

911

3032

RF420

NOMESCO Finland

2.7

77.5

581

1535

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.5

77.5

692

2017

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

77.4

1421

5624

C03DA01

ATC

spironolactone; oral

1.4

77.2

3654

18434

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

77.2

1836

7874

D07AA02

ATC

hydrocortisone; topical

1.3

77.2

5496

29777

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

77.2

1484

5967

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

77.0

2135

9549

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.0

76.9

1032

3638

M53.8

ICD-10 Finland

Other specified dorsopathies

4.3

76.8

315

523

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.9

76.7

1179

4386

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.8

76.5

1491

6020

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

76.4

1351

5281

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

76.1

4613

24344

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

76.0

2402

11103

S10

ICPC

Boil/carbuncle

1.6

75.8

2006

8861

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

75.8

798

2530

G01AF04

ATC

miconazole; vaginal

1.7

75.8

1771

7557

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

75.8

6270

34743

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

75.6

7514

42707

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

75.5

862

2837

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

75.4

3045

14877

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

75.2

1772

7576

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

75.2

1151

4275

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

74.8

2179

9866

R01AD05

ATC

budesonide; nasal

1.5

74.8

2994

14596

C09AA05

ATC

ramipril; oral

1.3

74.4

8802

51142

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

74.2

883

2962

ACC53

NOMESCO Finland

Release of ulnar nerve

2.7

74.1

567

1518

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.7

74.0

1787

7696

G43.8

ICD-10 Finland

Other migraine

2.6

73.8

593

1633

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

73.8

1025

3667

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.6

73.7

575

1556

S22

ICPC

Nail symptom/complaint

1.6

73.6

2054

9200

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

73.4

5142

27776

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

3.3

73.3

408

881

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.8

73.2

1474

6013

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.3

73.0

763

2409

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

73.0

2248

10321

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

72.8

3135

15515

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.3

72.8

720

2215

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

72.7

1037

3749

SPAT1050

SPAT

Extensive neurological examination

2.2

72.6

850

2828

L90

ICPC

Osteoarthrosis of knee

1.6

72.6

2016

9018

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

3.4

72.5

395

840

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.3

72.3

703

2143

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.5

72.2

641

1865

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

72.2

4178

21859

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

4.1

72.1

310

539

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.8

72.0

1380

5539

J04.0

ICD-10 Finland

Acute laryngitis

1.9

71.9

1184

4515

B02.9

ICD-10 Finland

Zoster without complication

1.6

71.9

1923

8516

N05BE01

ATC

buspirone; oral

1.9

71.8

1109

4133

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

71.7

1724

7414

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

71.5

1445

5899

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.4

71.5

4191

21978

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

71.4

981

3492

NG1DA

NOMESCO Finland

X-ray of knees

2.4

71.4

676

2035

XCK00

NOMESCO Finland

Perimetry

1.5

71.4

2346

10941

S83.2

ICD-10 Finland

Tear of meniscus, current

1.5

71.2

2620

12541

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

71.2

1369

5504

ZX120

NOMESCO Finland

Intravenous

1.4

71.1

3440

17420

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.3

71.0

288

474

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

70.9

2084

9459

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

70.9

1493

6174

207

Kela drug reimbursment

Chronic arrhythmias

1.4

70.9

4649

24841

G56.4

ICD-10 Finland

Causalgia

5.1

70.8

248

349

RF120

NOMESCO Finland

2.8

70.6

496

1259

C10AA03

ATC

pravastatin; oral

1.5

70.5

2324

10848

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.4

70.3

631

1845

XLA10

NOMESCO Finland

1.7

70.3

1749

7593

A10BH01

ATC

sitagliptin; oral

1.4

70.3

3196

15989

M53.9

ICD-10 Finland

Dorsopathy, unspecified

3.9

70.1

320

588

P74

ICPC

Anxiety disorder/anxiety state

1.7

70.1

1467

6056

H93.1

ICD-10 Finland

Tinnitus

1.5

70.0

2329

10891

G43

ICD-10 Finland

Migraine

1.7

69.8

1736

7538

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

69.8

7761

44711

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

69.8

2099

9583

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

69.7

1451

5978

G04BD11

ATC

fesoterodine; oral

2.0

69.7

1022

3735

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.7

69.6

1753

7638

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

69.5

1952

8756

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

69.5

1237

4846

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

69.4

974

3500

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

69.3

3576

18324

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.1

69.2

884

3056

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.2

69.1

737

2352

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

69.1

1045

3862

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

69.0

961

3442

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.8

68.8

1191

4622

M51

ICD-10 Finland

Other intervertebral disc disorders

4.7

68.8

258

392

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

7.1

68.7

185

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

68.6

1552

6557

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

68.5

600

1734

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.1

68.4

885

3074

B01AF02

ATC

apixaban; oral

1.4

68.4

3063

15276

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

68.4

2418

11466

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.2

68.4

758

2462

N03AF02

ATC

oxcarbazepine; oral

1.9

68.2

1172

4538

SPAT1043

SPAT

Audiometry

1.4

68.0

3465

17716

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

68.0

611

1791

N81.1

ICD-10 Finland

Cystocele

1.6

67.9

2059

9416

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

67.9

3988

20909

M24.2

ICD-10 Finland

Disorder of ligament

2.5

67.9

592

1706

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.4

67.8

4329

23018

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

67.8

1670

7233

F43.00

ICD-10 Finland

Acute stress reaction mild

2.0

67.7

963

3476

N02CC05

ATC

almotriptan; oral

1.7

67.7

1531

6467

N05AH03

ATC

olanzapine; systemic

1.5

67.7

2293

10770

M62.6

ICD-10 Finland

Muscle strain

1.9

67.6

1069

4019

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

67.5

2601

12570

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.2

67.5

399

902

SPAT1139

SPAT

Nutrition survey

1.8

67.5

1214

4773

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

67.4

1073

4040

SPAT1281

SPAT

Other administrative function

1.4

67.4

3022

15073

R07.2

ICD-10 Finland

Precordial pain

2.2

67.1

740

2399

205

Kela drug reimbursment

Chronic hypertension

1.2

67.1

9828

58448

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

67.1

1666

7230

G03CA04

ATC

estriol; systemic, vaginal

1.6

67.1

2110

9738

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

67.0

1472

6166

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

66.8

1331

5410

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.9

66.5

1110

4253

N07BC02

ATC

methadone; systemic

6.7

66.5

186

197

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

66.4

1294

5224

E66

ICD-10 Finland

Obesity

1.7

66.2

1570

6724

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

66.2

820

2799

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.1

66.2

853

2960

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

66.1

1215

4811

M41.8

ICD-10 Finland

Other forms of scoliosis

4.9

66.1

236

340

G44.0

ICD-10 Finland

Cluster headache syndrome

2.8

66.0

467

1192

N07CA01

ATC

betahistine; oral

1.5

66.0

2532

12224

M09AX01

ATC

hyaluronic acid; parenteral

1.7

66.0

1634

7085

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

65.9

1952

8872

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

65.8

3246

16492

1412

FHL

Laparoscopy and sterilization

1.6

65.8

2033

9340

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

65.7

5525

30637

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

2.1

65.7

823

2822

XX2CT

NOMESCO Finland

Other injection with CT guidance

6.8

65.6

183

193

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

5.7

65.5

207

258

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.4

65.3

613

1837

M15.8

ICD-10 Finland

Other polyarthrosis

2.4

65.3

590

1734

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

65.2

10023

59897

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

65.1

601

1787

L04AA13

ATC

leflunomide; oral

2.0

65.1

925

3339

K92.1

ICD-10 Finland

Melaena

1.6

65.0

1703

7498

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

65.0

3955

20858

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

65.0

5349

29567

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.9

64.9

425

1032

M10.9

ICD-10 Finland

Gout, unspecified

1.6

64.8

2065

9554

E000006

ATC

1.5

64.8

2591

12620

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

64.8

1678

7367

L19

ICPC

Muscle symptom/complaint NOS

2.0

64.7

893

3188

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

64.4

883

3143

NA2AD

NOMESCO Finland

Thoracic spine CT examination

4.2

64.4

269

456

Y6099

ICD-8 Finland

Prenatal care and observation

1.7

64.4

1421

5961

N02CC07

ATC

frovatriptan; oral

1.7

64.3

1558

6715

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.4

64.2

614

1857

M04AA01

ATC

allopurinol; systemic

1.4

64.2

4228

22587

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

2.3

64.2

620

1887

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

2.1

64.2

750

2497

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760892) CBC W Ordered Manual Differential panel - Blood

15143

77265

1.47

322.40

4.8

4.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6770

28695

1.71

318.43

7.2

8.3

122.8

121.6

g/l

5.06

6544

27645

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

13547

67899

1.49

313.77

1.7

1.6

50210558.0

32522759.9

pmol/l

2.01

11422

56432

(3020891) Body temperature

3386

11519

2.10

311.42

4.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4836

18711

1.86

308.40

7.1

24.7

24.5

mmol/l

2.60

4553

17394

(3002030) Lymphocytes/100 leukocytes in Blood

30397

166160

1.52

307.65

6.5

6.0

28.4

28.1

3.89

28431

155118

(3006315) Basophils [#/volume] in Blood

33292

169277

1.78

307.65

6.3

5.8

0.0

e9/l

2.68

29383

146692

(3009261) Glucose [Presence] in Urine by Test strip

32826

169139

1.73

307.65

4.5

3.4

0.0

estimate

0.51

5838

31587

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

22301

94238

2.00

307.65

2.4

2.1

183.1

215.5

u/l

5.44

21062

88332

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

39984

237329

1.47

307.65

3.6

2.9

49.6

45.9

u/l

10.77

37709

222720

(3022217) INR in Platelet poor plasma by Coagulation assay

9200

39607

1.72

307.65

23.2

23.4

1.3

inr

1.84

1262

5765

(3044889) 12 lead EKG panel

40911

232180

1.64

307.65

4.1

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

17053

72011

1.88

307.65

1.9

1.7

1.0

1.2

mg/l

19.30

12884

54556

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

52352

325900

1.71

307.65

15.5

11.9

83.6

83.8

ml/min/173m2

1.36

44448

266722

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

26947

136914

1.64

307.65

2.5

2.2

3422.4

76.4

nmol/l

0.50

24504

123988

(3011397) Hemoglobin [Presence] in Urine by Test strip

17372

75828

1.82

307.65

4.4

3.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21550

112196

1.51

307.65

3.4

3.2

32.4

33.4

u/l

1.01

20462

106346

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18387

84566

1.72

307.65

3.1

2.9

1158.9

1422.5

ng/l

12.94

15603

71641

(3021960) Folate [Moles/volume] in Serum or Plasma

15277

72381

1.61

307.65

1.6

1.5

20.3

nmol/l

0.03

13256

62452

(40761535) Cells panel - Urine sediment

7218

24475

2.18

307.65

4.0

3.3

—

(3008898) HLA-B27 [Presence]

3998

10928

2.64

307.65

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

33872

174300

1.76

307.65

6.3

5.8

2.0

1.9

e9/l

3.09

30462

153792

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

24936

115822

1.82

307.65

3.8

3.2

—

0.3

—

(3018418) pH of Serum or Plasma

20364

93251

1.76

307.65

4.2

4.1

7.4

0.66

3522

18164

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

57633

350203

2.85

307.65

18.5

12.7

20.7

23.6

mg/l

84.90

48639

273572

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

53472

339805

1.64

307.65

4.6

4.1

1.4

1.5

mmol/l

43.64

49948

315738

(3000963) Hemoglobin [Mass/volume] in Blood

60202

395061

2.61

307.65

26.7

18.9

134.9

135.8

g/l

49.17

59759

389564

(3007164) IgA [Mass/volume] in Serum or Plasma

13794

66648

1.56

307.65

1.5

1.4

2.3

2.4

g/l

0.83

8394

41295

(40761511) CBC panel - Blood by Automated count

57813

367501

2.24

307.65

16.7

12.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

30233

160549

1.59

307.65

4.4

3.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12465

54280

1.74

307.65

3.0

2.6

1.2

1.1

e6/l

0.29

7585

30073

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

26105

119078

1.89

307.65

4.2

3.3

49.8

65.2

ng/l

0.79

17231

76162

(3002582) Erythrocytes [#/volume] in Urine

20436

98584

1.65

307.65

3.7

3.1

56.1

96.3

e6/l

3.86

16317

74603

(40758558) Short blood count panel - Blood

16909

83802

1.55

307.65

6.6

6.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8431

33841

1.84

307.65

1.9

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

8017

34923

1.68

307.65

6.6

7.5

12.1

12.6

kpa

15.20

7680

33247

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

32506

158823

1.88

307.65

6.9

6.5

1.2

mmol/l

0.57

28018

133275

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

6154

25229

1.77

307.65

2.8

2.6

67.4

67.3

ml/min/173m2

0.11

2457

9888

(3024731) MCV [Entitic volume]

60196

394882

2.62

307.65

26.4

18.7

91.0

90.7

68.86

59751

389336

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

47026

266728

1.90

307.65

4.6

3.9

14.7

pmol/l

2.33

43544

243453

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

53973

331229

1.96

307.65

4.9

4.2

5.9

mmol/l

27.02

50128

304214

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

53861

342321

1.67

307.65

4.7

4.1

4.7

mmol/l

10.04

50569

319355

(3031040) Bacteria [#/volume] in Urine by Automated count

42458

223562

1.99

307.65

5.6

4.1

1334.5

1325.7

e6/l

0.01

528

3137

(3019309) Folate [Moles/volume] in Red Blood Cells

12587

57441

1.65

307.65

1.8

1.7

1211.8

1155.4

nmol/l

9.13

9908

43350

(3001122) Ferritin [Mass/volume] in Serum or Plasma

28324

154418

1.50

307.65

3.2

2.8

116.6

119.1

ug/l

0.76

26376

143829

(40768797) Stomach Pathology biopsy report

10082

43960

1.70

307.65

1.3

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

30041

163659

1.53

307.65

6.3

5.8

56.9

57.3

6.46

28166

153442

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7326

29632

1.81

307.65

2.2

362.6

378.8

nmol/l

8.72

6678

27373

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

25367

129926

1.60

307.65

4.7

3.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

17815

85942

1.61

307.65

2.6

2646.1

4431.7

umol/l

10.16

15378

75244

(3019069) Monocytes/100 leukocytes in Blood

29790

160855

1.54

307.65

6.7

6.2

8.4

8.5

6.32

27996

150899

(3019550) Sodium [Moles/volume] in Serum or Plasma

57869

352467

2.91

307.65

20.0

14.4

139.6

mmol/l

9.15

57022

342906

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

23643

102251

1.97

307.65

2.8

2.5

55.1

58.9

u/l

18.78

22035

94144

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

51343

310951

1.82

307.65

6.2

5.3

39.7

39.3

mmol/mol

15.63

48159

288937

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13341

60518

1.67

307.65

4.3

3.5

279.3

541.6

ng/l

10.50

9571

44960

(3023103) Potassium [Moles/volume] in Serum or Plasma

57945

353555

2.91

307.65

20.1

14.6

4.0

mmol/l

14.17

57027

343276

(3037522) Nuclear Ab [Titer] in Serum

11107

45395

1.85

307.65

1.4

1.3

519.9

546.4

titre

0.69

2188

9115

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

26195

131281

1.66

307.65

2.1

1.9

95.7

96.2

pmol/l

0.93

14068

69281

(3016502) Oxygen saturation in Arterial blood

7316

31060

1.72

307.65

6.8

7.9

95.7

0.26

7057

29870

(3026008) Bacteria identified in Urine by Culture

20916

96176

1.76

307.65

3.6

2.8

—

(3006504) Eosinophils/100 leukocytes in Blood

29634

159973

1.54

307.65

6.4

5.9

2.9

2.8

0.57

27736

149263

(3035941) MCH [Entitic mass]

60192

394835

2.62

307.65

26.4

18.7

30.3

30.2

18.77

59747

389303

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11087

51494

1.60

307.65

3.1

3.4

0.8

mmol/l

0.77

10314

48021

(3044640) Blood type and Crossmatch panel - Blood

20395

106296

1.49

307.65

2.6

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12328

56521

1.64

307.65

2.8

3.0

2.4

mmol/l

0.57

10819

49151

(3000850) Epithelial cells [#/volume] in Urine

15361

67340

1.77

307.65

2.8

2.5

5.8

e6/l

0.13

13615

58552

(36304419) Bacteria [Presence] in Urine

18658

87774

1.68

307.65

3.5

2.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3765

12599

2.14

307.65

1.3

1.2

0.9

0.8

u/ml

0.28

470

939

(42870588) Differential panel, method unspecified - Blood

22321

114480

1.55

307.65

6.1

5.9

—

(3001604) Monocytes [#/volume] in Blood

33136

168483

1.78

307.65

6.2

5.8

0.6

e9/l

6.19

29273

146042

(3007461) Platelets [#/volume] in Blood

60175

394519

2.62

307.65

26.5

18.8

255.8

252.7

e9/l

25.87

59273

384199

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8020

34945

1.68

307.65

6.6

7.5

5.1

kpa

1.89

7683

33280

(3048689) Calprotectin [Mass/mass] in Stool

9625

42489

1.68

307.65

2.3

2.4

123.4

133.6

ug/g

1.92

7574

33400

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

54750

347783

1.75

307.65

5.2

4.5

2.8

mmol/l

8.22

51093

322567

(3015377) Calcium [Moles/volume] in Serum or Plasma

21953

108053

1.63

307.65

3.1

3.4

2.4

mmol/l

0.65

19314

94597

(3023368) Bacteria identified in Blood by Culture

18074

85471

1.66

307.65

4.6

4.2

—

(3042936) Bacteria identified in Isolate by Culture

10031

45793

1.62

307.65

2.2

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

37432

195174

1.82

307.65

8.8

8.9

4.2

4.1

e9/l

3.41

33319

170363

(3020564) Creatinine [Moles/volume] in Serum or Plasma

58809

370794

2.74

307.65

20.2

14.6

75.7

76.5

umol/l

7.39

58788

370600

(3013707) Erythrocyte sedimentation rate by Westergren method

47627

249852

2.36

307.65

4.9

3.8

11.7

11.6

mm/h

1.87

44859

231417

(3026782) Osmolality of Urine

13368

63552

1.58

307.65

3.1

2.7

536.0

549.1

mosm/kgh2o

8.11

11583

53933

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6634

24905

1.95

307.65

2.6

2.2

5.2

7.8

ug/l

25.45

5777

21606

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8360

33726

1.83

307.65

1.9

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

32517

167400

1.72

307.65

5.7

4.6

0.0

estimate

0.06

5985

32526

(3019150) Specific gravity of Urine by Refractometry

16523

71179

1.83

307.65

4.9

3.7

1.0

kg/l

0.56

2061

11225

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11695

50260

1.76

307.65

2.0

1.8

—

(3010813) Leukocytes [#/volume] in Blood

60198

395013

2.61

307.65

26.6

18.8

6.9

6.7

e9/l

42.65

59196

383568

(3024561) Albumin [Mass/volume] in Serum or Plasma

28457

139637

1.76

307.65

4.8

35.9

35.7

g/l

7.82

26487

129414

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

29882

143247

1.86

307.65

6.2

5.9

1.2

mmol/l

0.16

27410

129621

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

47983

257643

2.26

307.65

8.1

7.2

76.1

77.4

u/l

8.29

45654

242378

(3007853) Bacteria identified in Skin by Aerobe culture

9001

38802

1.71

307.65

1.9

1.7

—

(3019060) Gas panel - Arterial blood

5091

19572

1.88

307.65

4.6

4.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

16213

76645

1.63

307.65

1.3

1.4

1.7

u/ml

3.76

4627

20814

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

9258

37935

1.81

307.65

8.1

6.5

—

(3022096) Basophils/100 leukocytes in Blood

28827

154975

1.54

307.65

6.5

6.0

0.7

0.69

26965

144662

(3033658) Prothrombin time (PT) actual/Normal

16669

83781

1.52

307.65

4.2

3.9

92.2

90.7

11.62

16102

81722

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

14786

55847

2.10

307.65

1.4

1.3

28.1

36.3

iu/ml

4.88

4321

17633

(3013826) Glucose [Moles/volume] in Serum or Plasma

37763

194041

1.89

307.65

5.3

4.5

6.6

6.7

mmol/l

15.50

35747

179339

(3014576) Chloride [Moles/volume] in Serum or Plasma

8716

38883

1.64

307.65

6.6

7.2

104.2

104.5

mmol/l

7.63

8511

38050

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

53379

318804

2.12

307.65

5.6

4.5

1.9

2.1

mu/l

1.63

49960

293851

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17246

81858

1.64

307.65

2.4

2.2

2.9

mg/l

0.17

14986

69770

(3015736) pH of Urine

26172

129338

1.69

307.65

4.1

3.1

5.4

5.8

—

100

(3018095) Leukocytes [#/volume] in Urine

23507

116960

1.63

307.65

4.3

3.5

70.5

99.5

e6/l

8.15

17704

80572

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5767

22678

1.84

307.65

1.7

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

43278

236353

1.88

307.65

5.1

4.0

—

(3003396) Base excess in Arterial blood by calculation

7991

34981

1.67

307.65

6.7

7.5

1.3

1.0

mmol/l

10.19

6316

27395

(3026361) Erythrocytes [#/volume] in Blood

60198

394922

2.62

307.65

26.5

18.7

4.5

e12/l

67.86

59201

383482

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

34576

170039

1.92

307.65

5.9

6.0

10.3

11.4

umol/l

57.34

32868

160644

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10937

51392

1.58

307.65

3.3

2.8

3.6

2.9

e6/l

7.30

6143

27322

(3035350) Ketones [Presence] in Urine by Test strip

32554

166961

1.74

307.65

4.4

3.3

0.0

estimate

1.02

5831

31710

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

58617

373019

2.48

307.65

12.2

9.6

26.7

26.5

u/l

1.20

57195

360126

(3032080) INR in Blood by Coagulation assay

25777

128583

1.66

307.65

9.0

8.4

1.2

inr

5.27

7534

38003

(3013115) Eosinophils [#/volume] in Blood

34251

174874

1.79

307.65

6.4

6.0

0.2

e9/l

3.69

30704

153760

(3030467) Casts [#/volume] in Urine by Automated count

19131

89684

1.69

307.65

3.6

3.0

0.3

0.4

e6/l

6.04

15006

66472

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15732

80251

1.48

307.65

2.5

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

14210

52237

2.15

307.65

1.3

1.2

8.3

12.2

u/ml

7.21

5533

20543

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

51779

327985

1.56

307.65

4.2

3.7

1.4

1.3

mmol/l

117.76

48100

303189

(3029937) Albumin [Presence] in Urine by Test strip

18946

88981

1.68

307.65

5.0

3.7

0.0

estimate

0.91

5847

31195

(4010399)

5588

22642

1.78

306.79

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4719

18248

1.86

301.16

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

18868

101576

1.41

295.92

3.3

3.2

7.6

7.9

mmol/l

1.05

15973

85758

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8863

41159

1.57

288.62

5.3

6.0

1.0

mmol/l

0.08

8221

38409

(3021589) Normoblasts [#/volume] in Blood

26585

152206

1.37

285.04

10.4

9.2

0.0

e9/l

0.64

22156

124889

(3004588) Protein electrophoresis panel - Serum or Plasma

4917

19601

1.80

283.91

2.5

2.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10166

48877

1.53

283.07

2.1

29.6

29.8

3.34

9851

47427

(3020630) Protein [Mass/volume] in Serum or Plasma

5810

24351

1.72

282.42

2.6

2.5

66.7

66.5

g/l

0.90

5237

22201

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5444

22450

1.75

280.09

2.4

2.3

28.5

22.7

au/ml

1.79

227

1448

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8134

37306

1.59

278.38

2.7

6.9

8.7

umol/l

12.88

6936

32277

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5041

20467

1.77

273.29

1.3

42.6

50.6

au/ml

1.32

173

856

(3014111) Lactate [Moles/volume] in Serum or Plasma

6289

27227

1.67

270.58

6.2

7.2

1.4

mmol/l

0.06

6076

26211

(3022948) Iron [Moles/volume] in Serum or Plasma

10504

51656

1.49

260.14

2.5

13.2

13.7

umol/l

0.68

9694

47873

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6778

30363

1.61

253.92

2.8

2.5

47.1

43.3

u/l

0.23

5795

26017

(3043409) Potassium [Moles/volume] in Arterial blood

2597

8699

2.12

247.33

4.3

4.5

3.8

3.9

mmol/l

2.06

2488

8120

(3018405) Lactate [Moles/volume] in Arterial blood

2907

10184

2.03

245.92

4.1

4.2

1.4

mmol/l

0.63

2869

9991

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6408

28523

1.62

245.80

3.9

5.9

5.8

kpa

5.94

6222

27664

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13253

68874

1.42

244.04

1.7

1.6

—

(3012516) Albumin [Mass/volume] in Urine

17030

92474

1.38

242.65

3.3

594.5

384.5

mg/l

4.88

10915

58712

(3012544) pH of Venous blood

6563

29575

1.60

238.94

3.9

7.4

0.06

151

(3002032) Base excess in Venous blood by calculation

6360

28462

1.61

238.20

3.9

2.0

1.8

mmol/l

5.24

5247

23236

(3005322) IgE [Units/volume] in Serum or Plasma

5066

21421

1.70

236.28

1.3

197.7

254.6

u/ml

3.71

4675

19854

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5306

22736

1.68

235.48

3.6

4.0

84.2

92.4

ng/l

7.69

4597

19654

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9651

47560

1.48

233.65

2.5

2.4

2.3

g/l

7.75

8931

43884

(3005719) IgG [Mass/volume] in Serum or Plasma

5630

24555

1.65

233.37

2.7

2.6

10.3

10.6

g/l

8.58

5113

22494

(3020682) Albumin/Creatinine [Ratio] in Urine

17732

97440

1.37

232.43

3.9

4.1

8.7

9.6

mg/mmol

1.60

11165

62133

(3024354) Oxygen [Partial pressure] in Venous blood

5333

23215

1.65

222.12

3.4

3.2

4.6

kpa

0.29

5160

22413

(3013512) EKG study

16703

91711

1.36

216.69

4.2

3.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

38840

240488

1.32

215.78

3.4

3.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4538

19080

1.70

215.19

8.0

9.7

93.8

93.9

1.06

4519

19010

(3000494) Fungus identified in Specimen by Culture

7944

38234

1.51

213.98

1.5

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8931

44088

1.47

212.17

2.6

22.1

23.0

7.74

7578

37693

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4519

19053

1.70

211.97

7.9

9.5

1.5

1.4

14.55

4489

18924

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4511

19025

1.69

211.34

8.0

9.6

0.7

14.54

4485

18907

(3003338) MCHC [Mass/volume]

47680

304593

1.36

210.77

23.2

16.1

332.3

332.7

g/l

17.65

47432

302101

(40768804) Tissue Pathology biopsy report

23876

138686

1.31

208.89

2.1

2.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3520

13969

1.79

203.78

3.0

2.9

1.4

1.3

15.37

3504

13895

(3013139) Helicobacter pylori Ag [Presence] in Stool

5025

22007

1.63

203.47

1.3

1.2

—

(3000991) Gas panel - Venous blood

5741

26030

1.58

201.53

7.5

8.7

—

(4034850)

2721

10013

1.92

199.38

10.6

9.1

—

(3002385) Erythrocyte distribution width [Ratio]

46346

295792

1.34

195.79

20.9

15.5

13.7

13.6

24.91

45724

289404

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3434

13689

1.78

195.61

3.0

2.9

0.7

0.07

3261

13175

(3025941) Bacteria identified in Stool by Culture

4554

19776

1.64

190.07

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2449

8875

1.95

187.44

1.4

281.0

273.8

ug/g

0.84

1380

5113

(3045414) Leukocytes [Presence] in Urine

3532

14421

1.74

185.04

2.0

1.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2677

10043

1.89

184.86

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

7158

34670

1.49

184.69

2.4

2.5

1.8

2.04

6321

30653

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2231

7944

1.98

179.41

1.3

516.7

538.0

mg/l

0.44

2127

7567

(3004119) Hemoglobin [Mass/volume] in Venous blood

4249

18390

1.65

179.24

3.4

129.7

129.3

g/l

0.40

4139

17979

(3022145) Colonoscopy Study observation

7510

37146

1.46

173.36

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4126

17935

1.64

170.80

1.8

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3259

13342

1.73

168.69

4.1

3.9

50.7

47.9

8.31

3225

13195

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8743

44701

1.41

168.13

2.0

1.7

1.5

1.4

20.38

7690

39718

(3014765) Yersinia sp identified in Stool by Organism specific culture

2518

9551

1.86

167.80

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2492

9466

1.86

165.28

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2511

9583

1.85

164.09

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

5418

25373

1.53

162.82

2.4

2.6

71.1

69.4

e9/l

2.23

4163

19021

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1977

6985

1.99

162.28

1.2

1.3

3.7

3.8

mmol/l

1.05

1861

6551

(3028026) IgM [Mass/volume] in Serum or Plasma

4285

19098

1.60

159.86

1.8

1.9

1.3

g/l

0.57

3887

17463

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5357

25203

1.52

157.29

3.0

2.8

171.5

205.9

ng/l

5.87

4864

22844

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1957

7015

1.96

154.13

1.4

2776.1

1825.7

e6/l

0.22

1644

5657

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1953

7011

1.96

153.16

1.3

1.4

19.1

33.7

e6/l

2.28

1560

5374

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4324

19523

1.58

152.43

3.4

3.5

5.2

5.1

kpa

5.75

4012

18015

(36660697) Celiac disease serology panel - Serum

5734

27553

1.49

151.80

1.2

—

(3009343) pH of Capillary blood

4265

19274

1.57

149.66

3.4

3.5

7.4

0.66

569

2584

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7234

36451

1.43

149.32

3.9

4.2

237.7

242.5

u/l

1.61

6804

34503

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2243

8536

1.85

147.64

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4130

18616

1.58

146.40

3.3

3.4

1.9

1.6

mmol/l

3.57

3043

13636

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4641

21668

1.52

140.41

3.1

3.4

4.5

pmol/l

3.85

4096

19395

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2540

10227

1.75

138.74

1.7

1.2

g/l

7.29

2408

9737

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3224

13853

1.65

138.74

1.4

1.6

10.8

15.1

u/ml

0.76

410

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2475

9928

1.76

136.92

1.7

0.2

g/l

1.81

2333

9425

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3152

13516

1.65

136.67

1.1

8.9

9.1

u/ml

0.01

195

(3027273) Bicarbonate [Moles/volume] in Venous blood

3350

14630

1.62

135.08

3.5

3.4

25.4

25.2

mmol/l

3.37

3246

14188

(3020961) Endomysium IgA Ab [Titer] in Serum

3652

16420

1.58

130.33

1.1

216.6

195.9

titre

0.13

444

(3000475) Leukocytes [#/volume] in Synovial fluid

1928

7273

1.87

130.23

1.7

1.6

12916.4

13395.4

e6/l

0.14

1427

5282

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6005

30011

1.43

128.27

2.2

2.3

0.2

g/l

1.67

5537

27911

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2671

11191

1.68

126.27

2.5

2.2

3.7

3.8

g/l

3.73

1929

7962

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2677

11227

1.68

126.10

2.5

2.1

7.4

7.3

g/l

1.43

2014

8354

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2672

11216

1.68

125.43

2.5

2.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2591

10787

1.69

125.39

2.3

435.1

549.1

ug/l

1.06

2386

10082

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2268

9116

1.75

124.42

1.3

23.9

38.1

u/ml

1.89

118

560

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2532

10557

1.69

121.81

2.5

2.2

3.0

3.1

g/l

0.83

1969

8181

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3141

13850

1.60

121.43

1.9

2.0

39.5

39.3

u/l

0.19

2825

12351

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3592

16384

1.55

120.09

2.5

2.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2500

10470

1.68

118.24

2.5

2.2

9.9

10.3

g/l

4.19

2089

8732

(3041096) Erythrocytes [Presence] in Urine by Automated

16179

94331

1.26

117.86

3.8

3.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2574

10876

1.67

117.73

1.6

176.3

306.4

titre

2.63

457

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

14982

86644

1.26

116.82

1.7

1.6

1.5

1.4

mmol/l

34.69

12691

73292

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2761

11921

1.63

116.10

2.1

2.0

1.7

2.4

ug/l

2.52

2428

10498

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3913

18330

1.51

115.66

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3891

18217

1.51

115.29

1.4

—

(3047181) Lactate [Moles/volume] in Blood

2363

9826

1.69

114.69

5.5

5.8

1.3

mmol/l

0.99

2097

8689

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3284

14850

1.56

113.89

4.2

4.3

24.3

24.1

mmol/l

3.51

2858

13412

(3003327) Ova and parasites identified in Stool by Light microscopy

2704

11684

1.63

113.30

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2698

11657

1.63

113.08

1.5

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1746

6696

1.83

111.82

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2032

8172

1.75

111.10

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1812

7052

1.81

110.65

2.3

2.1

—

(3017181) Myelocytes/100 leukocytes in Blood

5557

28087

1.41

110.41

4.2

4.1

0.9

0.20

1585

7638

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2075

8435

1.73

109.24

1.3

9.1

8.4

u/ml

0.14

294

1341

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1744

6762

1.81

107.79

1.3

1.2

38.7

44.4

u/ml

0.70

176

657

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2277

9534

1.68

107.62

2.6

2.3

0.9

0.8

g/l

0.14

1966

8176

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

650

1694

2.68

107.40

1.5

1.4

5.4

6.1

u/l

1.21

552

1412

(3020779) Urea [Moles/volume] in Serum or Plasma

5508

28005

1.40

105.46

7.0

7.6

9.4

9.7

mmol/l

3.55

5227

26628

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2037

8320

1.72

105.40

1.3

7.2

6.6

u/ml

0.09

198

879

(3028707) Methadone [Presence] in Urine by Screen method

1697

6570

1.81

105.37

3.8

2.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2428

10414

1.64

104.60

1.6

11.1

5.3

iu/ml

0.53

540

2140

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1772

6988

1.78

103.52

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2794

12472

1.58

102.19

5.0

0.9

1.39

2636

11681

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3595

16972

1.50

101.94

2.8

2.7

0.3

e6/l

0.70

3498

16487

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3588

16935

1.50

101.86

8.7

9.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4921

24694

1.41

101.40

1.2

122.0

145.7

iu/ml

4.24

1886

9286

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2828

12717

1.57

100.17

5.0

1.8

1.7

6.34

2667

11912

(3052851) Hemolysis interference index of Serum or Plasma

2273

9692

1.65

100.14

3.1

3.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

5058

25559

1.41

100.09

3.9

0.6

0.7

1.41

1107

5558

(3023511) Choriogonadotropin [Units/volume] in Urine

1960

8034

1.71

100.08

1.5

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1339

4900

1.91

99.02

1.3

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

8048

43823

1.31

98.27

1.6

—

(3022621) pH of Urine by Test strip

4370

21595

1.43

97.89

3.1

2.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

5242

26796

1.39

96.77

4.2

4.1

0.1

0.61

1438

7111

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2147

9118

1.66

96.02

3.6

3.2

44.1

42.8

mg/l

0.09

1744

7355

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2071

8714

1.67

95.96

2.4

2.1

37.9

37.8

g/l

0.36

1803

7450

(3034860) Kappa light chains.free [Mass/volume] in Serum

2149

9132

1.65

95.88

3.6

3.2

65.0

65.4

mg/l

0.01

1748

7358

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2093

8852

1.66

95.09

3.5

3.2

2.3

4.7

ratio

1.41

184

676

(3017315) Amylase [Enzymatic activity/volume] in Urine

598

1593

2.62

94.76

1.4

1.2

241.0

338.1

u/l

1.53

572

1478

(3019225) pH of Specimen

5973

31377

1.35

92.83

4.5

4.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1675

6709

1.75

92.73

1.3

1.2

8.5

16.4

u/ml

0.58

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2011

8475

1.67

92.59

2.4

2.2

0.0

g/l

0.97

1851

7725

(3025159) Blasts/100 leukocytes in Blood

4957

25303

1.39

92.06

4.3

4.2

0.1

0.2

0.62

1201

6035

(3000492) Spirometry study

6328

33578

1.34

91.98

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

49790

329303

1.24

91.40

18.5

13.7

39.9

40.0

0.34

35215

247235

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1683

6791

1.74

90.80

1.3

1.2

3.5

5.9

u/ml

1.06

131

512

(3022313) Gas panel - Capillary blood

2953

13844

1.50

86.23

3.5

3.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

520

1371

2.64

84.13

2.2

2.0

119.4

142.0

umol/l

0.81

274

692

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5045

26243

1.36

82.98

3.9

3.8

1.2

mmol/l

0.33

4446

22873

(3037756) Immunofixation for Serum or Plasma

1489

5967

1.75

82.25

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1441

5721

1.76

82.20

1.7

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1845

7842

1.65

82.13

2.5

2.2

0.0

g/l

0.44

1689

7118

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2603

12009

1.53

81.90

3.6

3.7

24.9

24.8

mmol/l

1.96

2417

11098

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3864

19270

1.42

81.72

6.6

7.2

25.0

24.7

mmol/l

5.61

3827

19090

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1815

7740

1.64

79.74

2.5

2.2

0.0

g/l

0.00

1683

7100

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2034

8949

1.60

78.78

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1634

6829

1.68

77.55

3.6

3.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

953

3393

1.96

76.36

1.1

69.9

66.3

au/ml

0.05

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

801

2682

2.09

75.88

1.1

1.2

37.6

43.7

mg/l

2.79

687

2221

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1568

6533

1.68

75.27

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1324

5278

1.76

74.47

1.5

1.6

0.7

0.8

g/l

3.62

991

3969

(3044941) Cell count panel - Synovial fluid

1215

4725

1.80

74.28

1.5

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

962

3471

1.94

74.18

1.1

55.7

18.4

au/ml

—

(3039000) Anion gap in Blood

1624

6883

1.65

73.05

6.3

6.8

11.1

11.3

mmol/l

0.91

1479

6194

(3018572) Chloride [Moles/volume] in Blood

1624

6884

1.65

73.01

6.3

6.8

105.0

105.1

mmol/l

0.30

1479

6196

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

771

2587

2.08

72.66

1.1

256.8

263.9

mg/l

0.35

681

2264

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7314

40794

1.28

72.35

1.7

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1590

6732

1.65

71.80

1.4

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1811

7924

1.60

71.72

2.9

3.0

24.9

24.6

mmol/l

3.04

1600

6972

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1589

6729

1.65

71.70

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

811

2790

2.03

71.51

1.4

103970.5

110111.0

e6/l

0.09

567

1905

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

752

2515

2.09

71.48

1.1

—

(3017732) Neutrophils [#/volume] in Blood

4541

23789

1.35

70.83

2.6

2.8

4.1

e9/l

0.11

3497

18636

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2671

12785

1.47

70.10

1.6

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3303

16493

1.41

69.02

8.5

9.7

24.5

24.3

mmol/l

3.79

3054

15409

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2216

10247

1.52

68.82

2.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1138

4441

1.79

68.79

1.3

0.2

nmol/l

0.03

281

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

949

3497

1.90

68.77

1.4

1.3

42.9

25.4

nmol/l

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1486

6253

1.66

68.70

1.2

53.3

139.5

titre

2.90

133

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1150

4504

1.79

68.69

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1632

7035

1.63

68.66

2.7

2.9

8.3

kpa

0.16

1535

6517

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2125

9772

1.53

67.70

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

667

2177

2.14

67.52

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

906

3315

1.91

67.07

1.4

6.3

6.9

g/l

4.20

645

2275

(3024139) IgG subclass 3 [Mass/volume] in Serum

904

3311

1.91

66.73

1.4

0.4

g/l

0.00

649

2280

(3028192) IgG subclass 2 [Mass/volume] in Serum

904

3313

1.91

66.61

1.4

2.8

3.0

g/l

2.08

642

2276

(3011288) Drugs identified in Urine by Screen method

2285

10711

1.50

66.48

4.2

2.9

—

(3049717) Cytology report of Urine Cyto stain

2409

11434

1.48

65.92

2.5

2.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1131

4463

1.77

65.87

1.3

nmol/l

0.03

1084

4303

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

659

2167

2.12

65.47

1.2

—

(4062490)

902

3323

1.90

65.43

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

4513

40418

0.76

65.04

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1205

4867

1.73

64.76

1.4

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1944

8854

1.54

64.70

2.0

2.1

10.9

10.8

mg/l

0.12

1800

8286

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

567

1764

2.24

64.54

1.1

2.5

5.8

nmol/l

1.54

105

348

(3003181) Sodium [Moles/volume] in Urine

1236

5042

1.71

64.12

1.4

62.8

62.7

mmol/l

0.03

992

3956

(3021788) Differential panel - Synovial fluid

1358

5695

1.67

63.60

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

507

1521

2.32

62.78

1.9

2.1

17.7

24.2

umol/l

0.90

155

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5962

32988

1.28

62.21

4.0

3.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1031

4029

1.79

62.06

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2880

14304

1.42

61.89

1.6

1.8

1.6

1.5

g/l

2.29

2454

12234

(3039162) Centromere protein B Ab [Units/volume] in Serum

1042

4089

1.78

61.86

1.3

1.2

46.1

53.1

u/ml

0.40

250

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1660

7375

1.58

61.62

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

768

2753

1.95

60.43

1.7

1.4

1.5

1.4

promille

0.72

572

2145

(3034770) Mitochondria Ab [Titer] in Serum

1972

9151

1.51

60.16

1.2

961.7

935.3

titre

0.05

257

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

417

1171

2.48

59.62

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2523

12322

1.44

59.45

3.2

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1324

5617

1.65

59.32

1.4

1.3

25.3

25.1

u/l

0.05

1066

4666

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1599

7116

1.57

58.92

1.6

—

(3000330) Specific gravity of Urine by Test strip

3117

15869

1.38

57.87

3.7

3.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

7729

44435

1.24

57.61

2.2

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1269

5366

1.65

57.59

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

798

2948

1.89

57.46

2.3

2.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1925

8981

1.50

57.23

1.4

15.8

13.9

iu/ml

0.20

215

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2728

13611

1.41

57.04

2.2

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

823

3097

1.85

56.00

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1014

4067

1.74

55.89

6.4

6.1

11.8

11.3

mg/l

2.08

931

3730

(3007566) Smooth muscle Ab [Titer] in Serum

1979

9334

1.49

55.79

1.2

117.2

119.8

titre

0.05

188

847

(4027681)

609

2075

2.05

55.23

1.2

1.3

—

(3021901) Oxygen saturation in Capillary blood

1336

5788

1.61

55.08

2.7

2.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1166

4907

1.66

53.91

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

341

912

2.60

53.88

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2419

23148

0.71

53.67

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3464

18188

1.34

52.69

1.4

1.3

27.0

26.6

iu/l

0.23

2992

15684

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2075

10004

1.45

52.30

1.1

6.3

5.2

u/ml

0.44

210

1383

(3023183) Ammonium ion [Moles/volume] in Plasma

1470

6595

1.56

52.30

2.9

2.7

33.1

34.1

umol/l

0.77

1245

5569

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3203

16669

1.35

51.65

2.4

2.3

6253.3

6045.1

u/l

0.12

1105

6821

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

364

1030

2.46

51.31

2.2

2.0

62.4

57.9

ug/l

0.54

356

1006

(3035637) Corticotropin [Mass/volume] in Plasma

974

3970

1.71

50.74

1.6

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2482

12434

1.40

50.61

2.0

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

790

3032

1.82

50.54

1.4

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

10055

60017

1.19

50.34

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

539

1820

2.06

50.13

1.1

1.0

1.1

u/l

0.52

235

829

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

8396

49319

1.21

49.94

2.3

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1089

4598

1.65

49.75

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4094

35903

0.78

49.28

1.7

—

(1616796) Gas panel - Central venous blood

1587

7337

1.51

49.26

3.6

3.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1783

8450

1.48

49.06

1.9

30.9

15.4

iu/l

0.46

632

3141

(3004616) Nuclear Ab [Presence] in Serum

959

3999

1.67

45.97

1.4

1.3

—

(3044927) Protein electrophoresis panel - Urine

722

2778

1.81

45.86

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

755

2946

1.79

45.80

1.5

1.6

29.8

31.6

0.68

461

1861

(3016879) Cocaine [Presence] in Urine

2859

14911

1.35

45.35

3.0

2.0

—

(3010421) pH of Blood

1787

8604

1.45

45.34

4.1

3.8

7.4

0.19

1537

7306

(3019420) Tryptase [Mass/volume] in Serum or Plasma

510

1758

2.02

44.94

1.5

8.5

7.7

ug/l

0.33

465

1591

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

473

1586

2.08

44.88

1.2

1.3

61.6

63.5

0.13

196

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

670

2543

1.84

44.48

1.2

1.3

1.9

2.1

mmol/l

5.20

617

2358

(3000764) Benzodiazepines [Presence] in Urine

3038

16039

1.33

44.36

3.0

2.0

—

(3024928) Oxygen saturation in Venous blood

1422

6568

1.51

44.35

3.1

3.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2080

10343

1.41

44.23

3.1

0.4

0.3

u/ml

1.31

1243

5818

(40767503) Oxygen content in Capillary blood by calculation

1484

6923

1.50

44.13

2.6

2.5

16.6

16.5

0.26

800

3536

(3027315) Oxygen [Partial pressure] in Blood

1586

7516

1.48

43.66

4.2

3.8

8.6

8.7

kpa

1.12

1549

7338

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1187

5290

1.57

43.52

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4651

26026

1.26

43.40

2.4

2.2

12.0

12.4

nmol/l

2.66

4088

23216

(4198724)

486

1670

2.03

43.22

3.0

2.1

—

(3028300) Cannabinoids [Presence] in Urine

3051

16184

1.32

43.08

3.0

2.0

—

(3012501) Base excess in Blood by calculation

1574

7475

1.47

42.87

4.2

3.8

2.5

mmol/l

0.05

1090

4980

(3013290) Carbon dioxide [Partial pressure] in Blood

1574

7477

1.47

42.81

4.2

3.8

5.0

kpa

1.68

1537

7300

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

940

3975

1.65

42.75

1.4

—

(3036489) Thrombin time

2496

12866

1.36

42.70

2.0

2.1

21.3

21.4

0.28

2123

11161

(3023419) Bacteria identified in Sputum by Culture

889

3715

1.67

42.31

2.6

2.4

—

(3016018) Differential panel - Cerebral spinal fluid

860

3565

1.68

42.19

1.3

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

983

4234

1.62

41.58

1.5

1.4

—

(3027008) Opiates [Presence] in Urine

3032

16152

1.32

41.51

2.8

2.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

965

4150

1.62

41.08

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

899

9902

0.62

41.01

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

900

9880

0.63

40.46

1.4

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

703

2788

1.76

40.43

1.4

1.3

1.6

1.4

nmol/l

3.37

646

2514

(44806118)

821

3403

1.68

40.32

1.5

—

(44790049)

821

3404

1.68

40.27

1.5

—

(44790048)

821

3405

1.68

40.23

1.5

—

(44790047)

821

3405

1.68

40.23

1.5

—

(3011985) Renin [Units/volume] in Plasma

1009

4410

1.60

40.21

1.5

1.6

63.7

62.5

mu/l

0.06

898

3953

(3043238) Trisomy 21 risk [Likelihood] in Fetus

930

10113

0.63

40.07

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1560

7506

1.45

39.73

2.2

131.2

130.5

g/l

0.50

1167

5493

(3028271) Lactate [Moles/volume] in Capillary blood

1136

5128

1.55

39.40

2.0

1.8

1.7

mmol/l

0.63

1113

5003

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1836

9122

1.41

39.23

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1513

7258

1.46

39.15

2.0

1.9

187.1

195.7

pmol/l

2.58

1426

6908

(3022806) Fractional oxyhemoglobin in Capillary blood

958

4170

1.60

38.85

2.0

1.8

89.9

0.07

941

4108

(40768443) Skin Pathology biopsy report

2738

14517

1.32

38.73

1.2

—

(44813793)

626

2435

1.79

38.46

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

660

2608

1.76

38.46

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

660

2608

1.76

38.46

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

660

2608

1.76

38.46

1.5

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1179

12091

0.67

38.30

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1187

12153

0.67

38.24

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1184

12125

0.67

38.18

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1187

12146

0.67

38.12

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

694

2790

1.73

38.10

2.9

2.4

0.4

0.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2182

11215

1.36

37.99

1.4

10.5

9.6

u/l

1.92

1781

9226

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1906

9584

1.39

37.97

1.8

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1285

12924

0.68

37.67

1.4

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1097

4964

1.54

37.65

1.1

—

(3027944) Amphetamines [Presence] in Urine

2954

15894

1.30

37.56

2.8

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2717

24250

0.77

37.07

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

779

3262

1.66

36.86

1.6

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

662

2656

1.74

36.63

1.7

2.1

18.6

18.9

nmol/l

0.37

623

2514

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4011

22490

1.25

36.56

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1075

4880

1.54

36.38

5.1

353.4

369.0

umol/l

2.95

939

4213

(3045716) Anion gap in Serum or Plasma

393

1338

2.04

35.94

2.6

2.4

8.7

9.3

mmol/l

1.75

275

991

(3024263) Appearance of Synovial fluid

442

1571

1.96

35.89

1.9

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

905

3965

1.59

35.76

1.5

1.6

56.0

56.9

0.22

531

2577

(3013166) Neutrophils/100 leukocytes in Synovial fluid

293

888

2.29

35.74

1.3

1.4

53.8

54.8

0.15

249

761

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

545

2090

1.82

35.14

1.5

22.2

25.2

u/ml

0.64

418

(3023410) Appearance of Cerebral spinal fluid

776

3306

1.64

34.38

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

957

4293

1.55

34.19

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

713

2984

1.66

33.86

1.6

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

883

3900

1.58

33.75

2.1

2.0

24.4

26.7

mg/l

0.61

234

1050

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

635

2585

1.71

33.42

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

634

2580

1.71

33.41

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

17418

131135

0.89

33.39

2.8

2.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

634

2582

1.71

33.32

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

926

4148

1.56

33.31

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1046

4818

1.51

33.14

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

629

2562

1.71

33.04

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

924

4145

1.55

33.03

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

628

2560

1.71

32.90

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

168

402

2.90

32.87

3.7

2.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

627

2557

1.71

32.80

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

931

4193

1.55

32.70

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5507

32271

1.20

32.58

3.3

4.1

18.7

25.8

ug/l

1.17

4327

25780

(3050129) First trimester maternal screen panel - Serum or Plasma

1618

15261

0.73

32.47

1.5

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

465

1741

1.86

32.40

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

930

4199

1.54

32.31

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

912

4101

1.55

32.27

1.4

303.0

303.4

pmol/l

0.01

737

3161

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4900

28440

1.21

32.05

2.1

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

919

4147

1.54

32.01

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1412

6949

1.42

31.88

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1071

4999

1.49

31.87

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

347

1183

2.04

31.70

1.3

1.2

0.3

g/l

0.10

280

929

(3045424) Erythrocytes [Presence] in Urine

1192

5693

1.46

31.62

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1185

5661

1.46

31.40

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

412

1499

1.91

31.34

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

326

1100

2.06

30.64

1.3

1.2

109.1

111.7

0.96

287

984

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1129

5372

1.47

30.55

1.1

12.6

11.5

au/ml

0.12

360

(3037121) Protein [Mass/volume] in Urine

2119

11204

1.32

30.53

2.8

3.2

0.3

g/l

0.54

905

5009

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3177

17698

1.26

30.53

2.7

3.2

48.8

50.1

u/ml

0.07

3041

17111

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4845

28238

1.21

30.27

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1390

6891

1.41

30.13

1.8

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

771

3400

1.58

29.74

1.2

55.2

64.5

u/l

3.25

543

2280

(3020876) Protein [Mass/time] in 24 hour Urine

618

2585

1.66

29.49

2.0

0.6

1.1

g/24h

1.51

146

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

353

1245

1.97

29.42

1.1

419.0

571.6

ng/l

0.31

299

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

800

3576

1.56

29.11

2.6

3.4

5.1

7.6

nmol/l

0.83

767

3474

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1119

5375

1.45

28.86

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

223

661

2.34

28.73

1.5

1.6

0.4

ug/l

0.14

144

439

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

598

2499

1.67

28.65

1.1

287.2

410.9

mg/l

0.53

537

2242

(3035947) Staphylolysin Ab [Units/volume] in Serum

420

1588

1.84

28.46

1.2

1.1

3.3

4.2

iu/ml

0.93

133

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1225

6000

1.42

28.45

2.8

3.2

—

(3038026) Centromere Ab [Units/volume] in Serum

616

2602

1.65

28.33

1.3

1.2

73.6

47.2

u/ml

0.68

123

(3020717) Zinc [Moles/volume] in Serum or Plasma

421

1596

1.83

28.29

1.6

1.4

21.1

25.9

umol/l

2.89

400

1516

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1994

10572

1.32

28.19

1.9

1.7

39.6

41.5

nmol/l

3.02

1954

10321

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

390

1447

1.87

28.04

1.8

2.3

79.9

196.7

ug/l

0.65

373

1381

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

479

1894

1.76

28.03

1.3

1.2

93.8

90.2

u/l

0.31

423

1662

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

403

1512

1.85

27.99

1.5

1.6

2.6

8.7

nmol/l

0.96

334

1263

(3021387) Prolactin [Units/volume] in Serum or Plasma

2608

14352

1.27

27.74

1.6

300.9

312.5

mu/l

0.74

2370

12922

(3023420) DNA double strand Ab [Units/volume] in Serum

815

3703

1.53

27.60

1.6

27.0

35.3

iu/ml

1.10

175

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

466

1838

1.76

27.51

1.3

1.2

28.7

23.5

u/l

1.19

405

1586

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

597

2539

1.64

26.77

1.3

1.2

63.1

71.9

u/ml

0.27

112

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

597

2546

1.63

26.49

1.3

1.2

40.0

47.1

u/ml

0.30

183

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1353

6827

1.38

26.48

5.3

5.7

3981.2

1184.9

iu/ml

0.39

188

1005

(3011412) CD3 cells [#/volume] in Blood

717

3196

1.56

26.47

2.4

2.3

1.2

1.1

e9/l

1.83

430

1895

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

790

3600

1.53

26.42

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

513

2107

1.69

26.28

1.1

9.8

8.1

iu/ml

0.62

106

570

(3016650) Hepatitis A virus Ab [Presence] in Serum

1169

5761

1.41

26.27

1.1

—

(3016038) Potassium [Moles/volume] in Urine

472

1899

1.73

26.05

1.2

32.9

34.3

mmol/l

0.69

396

1634

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

437

1722

1.77

25.92

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

203

607

2.32

25.71

1.3

—

(4094501)

1661

8713

1.33

25.33

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

273

931

2.04

25.06

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

570

2438

1.63

25.03

1.3

1.2

13.4

8.6

u/ml

0.34

171

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

455

1835

1.72

24.93

1.3

560.4

413.1

titre

0.28

140

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1489

7704

1.35

24.91

2.3

2.4

117.3

109.7

ug/min

0.23

859

4635

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

540

2286

1.64

24.71

2.4

2.5

519.4

533.2

e6/l

0.22

457

1914

(4306422)

1083

5324

1.42

24.70

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2030

10996

1.29

24.50

1.9

1.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

443

1783

1.73

24.46

1.3

73.4

76.1

titre

0.06

153

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

506

2113

1.67

24.41

2.5

3.5

85.4

137.9

nmol/l

6.24

495

2073

(3002256) Pathology report gross observation

7267

44533

1.15

24.29

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

517

2178

1.65

24.12

3.2

29.3

27.4

mu/l

0.47

495

2034

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

517

5714

0.62

24.09

1.2

—

(3008295) Osmolality of Serum or Plasma

674

3033

1.55

23.92

1.4

1.5

278.7

279.8

mosm/kgh2o

0.55

507

2378

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2240

12349

1.27

23.49

1.3

198.1

228.1

miu/ml

3.83

994

5785

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

541

2325

1.62

23.35

2.2

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

650

2927

1.55

23.02

2.9

2.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

517

2218

1.62

22.50

2.4

2.5

0.2

e9/l

0.50

455

1914

(3014271) Vancomycin [Susceptibility]

378

1490

1.76

22.49

3.2

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2140

11811

1.27

22.24

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

110

260

2.94

22.17

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

312

1165

1.86

22.13

1.4

14.2

14.9

pmol/l

1.11

251

988

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

111

265

2.91

22.00

1.1

1.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.89

21.89

1.6

290.3

262.1

nmol/l

0.10

(1175426) CD3 cells/100 lymphocytes in Blood

570

2527

1.57

21.66

2.2

2.0

74.2

72.8

1.56

545

2428

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

461

1950

1.64

21.25

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

573

2555

1.56

21.25

1.3

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

227

770

2.05

21.24

1.4

1.3

17.0

16.9

umol/l

0.11

206

679

(40761536) Microorganisms panel - Urine sediment

5011

30177

1.16

21.09

4.8

3.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

467

1986

1.64

21.08

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1029

5159

1.39

21.03

1.1

124.2

117.2

8.88

921

4678

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

305

1154

1.84

20.80

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

430

1797

1.66

20.78

2.0

2.6

993.4

1042.7

u/ml

0.10

423

1775

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

535

2362

1.58

20.72

1.9

1.8

3.6

3.8

mg/l

0.42

503

2254

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

558

2490

1.56

20.64

2.2

2.0

14.4

14.0

0.23

280

1136

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1065

5388

1.38

20.62

1.2

1.3

3.8

3.9

u/ml

0.03

443

2445

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

916

4523

1.41

20.47

1.1

1.5

g/l

1.26

822

4101

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

813

3930

1.44

20.43

1.1

1.3

2.1

iu/ml

1.04

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1057

5351

1.38

20.39

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.12

20.38

1.5

1.6

234.7

244.9

nmol/l

0.05

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

554

2477

1.56

20.33

1.3

0.9

1.3

u/ml

0.74

249

1092

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

311

1194

1.81

20.26

2.7

2.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1830

10031

1.27

20.15

2.5

181.9

186.7

1.46

1695

9522

(46235355) HIV 1 and 2 tests - Meaningful Use set

11832

75448

1.11

20.05

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1287

6737

1.33

20.00

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

121

321

2.62

19.81

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

330

1301

1.76

19.70

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

289

1095

1.83

19.66

1.1

—

(3002619) Bacteria identified in Specimen by Culture

192

632

2.11

19.48

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1252

11375

0.76

19.46

1.4

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1386

7362

1.31

19.44

1.1

1.9

1.6

u/ml

0.33

567

2933

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6509

40161

1.14

19.39

4.6

4.2

31.4

32.3

8.75

4672

28017

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

911

8663

0.73

19.35

1.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

269

1004

1.86

19.20

1.2

22.8

19.9

0.21

175

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1884

10431

1.26

19.10

2.6

3.6

g/l

0.02

1779

9946

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

192

639

2.09

18.95

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

374

1546

1.68

18.89

1.5

1.6

7.3

5.1

mmol/24h

2.00

116

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

226

801

1.96

18.81

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1255

6609

1.32

18.74

1.1

4.3

5.7

u/ml

2.32

646

3354

(3040151) Glucose [Moles/volume] in Capillary blood

762

3704

1.43

18.64

8.2

8.0

7.4

7.3

mmol/l

0.21

626

3022

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1960

10944

1.25

18.48

2.2

94.3

91.9

4.47

1802

10180

(3017704) Immunofixation for Urine

379

1582

1.67

18.47

1.7

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

117

317

2.56

18.42

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

190

637

2.07

18.42

1.1

1.0

2.9

umol/24h

0.40

331

(3004451) EKG impression Narrative

351

1438

1.70

18.35

1.4

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

622

2918

1.48

18.30

3.7

3.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

456

2004

1.58

18.10

2.8

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9854

62557

1.11

17.94

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

717

3483

1.43

17.63

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

328

1334

1.71

17.63

1.7

2.1

2.0

umol/l

2.07

299

1259

(3042631) Mycobacterium sp identified in Specimen

838

4187

1.39

17.57

2.7

2.5

—

(3019977) pH of Arterial blood

397

1701

1.62

17.51

2.8

2.4

7.4

0.06

119

607

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1045

5416

1.34

17.43

3.3

3.1

0.8

nmol/l

0.84

822

4159

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

528

2420

1.52

17.41

2.4

2.5

782.8

728.6

e6/l

0.43

219

993

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1241

6597

1.31

17.36

2.1

0.9

0.8

nmol/l

1.25

1048

5526

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

220

797

1.92

17.24

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

284

1116

1.77

17.23

1.1

100.0

90.2

3.66

121

540

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1073

5595

1.34

17.19

1.2

1.3

3.4

3.7

u/ml

0.23

323

1977

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

383

1635

1.63

17.16

1.9

136.2

142.9

0.97

356

1542

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1180

6240

1.32

17.15

2.8

3.4

385.9

865.2

u/ml

1.98

1065

5659

(3026470) Cobalt [Mass/volume] in Blood

403

1744

1.61

17.09

2.0

4.3

3.6

ug/l

0.75

350

1536

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

289

1147

1.75

16.96

1.1

95.4

89.7

2.20

121

554

(3004809) Band form neutrophils/100 leukocytes in Blood

1009

5225

1.34

16.94

3.1

3.2

1.3

1.5

0.70

755

4049

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

221

809

1.90

16.81

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

471

2124

1.54

16.75

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

304

1230

1.72

16.68

2.1

2.0

28.7

29.5

0.46

289

1161

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

428

1896

1.57

16.47

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

698

3420

1.42

16.41

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1181

6288

1.31

16.36

1.1

1.0

1.1

u/ml

0.19

495

2599

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

215

2.81

16.36

1.4

1.5

40.4

37.5

0.22

146

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

298

1208

1.71

16.26

2.1

2.0

8.6

9.4

mg/l

1.84

243

960

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

496

2278

1.51

16.24

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1162

10403

0.77

16.22

1.9

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

307

1256

1.70

16.20

2.1

8.7

10.2

2.02

287

1161

(3034988) Calcium [Moles/volume] in Capillary blood

161

533

2.10

16.20

1.6

1.9

1.2

mmol/l

0.39

155

510

(3035320) C reactive protein [Mass/volume] in Body fluid

516

2396

1.50

16.04

2.7

2.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

522

2430

1.49

16.03

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

760

3796

1.39

16.02

1.1

97.5

95.4

1.28

707

3556

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2345

13544

1.21

16.02

2.2

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

949

4918

1.34

15.89

1.3

37.9

34.2

u/l

0.36

835

4277

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

391

1711

1.59

15.88

1.5

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

288

1165

1.72

15.85

1.1

115.2

108.2

2.01

252

1061

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

421

1879

1.56

15.72

1.0

265.2

343.4

ng/l

3.15

268

1371

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

202

735

1.91

15.69

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

217

809

1.86

15.66

1.1

—

(3051339) Copper [Moles/volume] in Blood

142

3.23

15.65

1.2

1.3

16.0

16.9

umol/l

0.86

118

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

423

1894

1.55

15.58

1.0

36.2

42.8

ng/l

2.50

260

1361

(3036180) Methadone [Presence] in Urine

4.70

15.56

3.1

2.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

214

796

1.87

15.56

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

342

1456

1.63

15.55

2.2

2.1

77.2

104.8

ug/min

0.42

339

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

422

1891

1.55

15.49

1.0

772.4

742.4

ng/l

0.58

254

1335

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

231

882

1.82

15.47

1.6

9.3

9.0

ug/l

0.39

231

882

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

151

497

2.11

15.45

1.6

1.9

1.2

mmol/l

0.16

146

476

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

202

740

1.90

15.38

1.1

1.3

95.8

93.9

0.43

197

730

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

12517

80904

1.09

15.37

4.3

4.1

21.8

22.0

0.43

5642

37669

(3025577) Chromium [Mass/volume] in Blood

386

1701

1.58

15.24

2.0

2.1

2.6

2.3

ug/l

0.66

321

1425

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

573

2747

1.45

15.21

1.2

145.4

188.7

titre

0.67

471

(3017354) Segmented neutrophils/100 leukocytes in Blood

648

3178

1.42

15.21

3.1

3.2

60.3

58.2

1.42

402

2038

(3034891) Synovial lining cells/100 cells in Synovial fluid

358

1555

1.60

15.03

1.5

6.1

3.8

1.40

360

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

218

826

1.83

14.98

1.3

143.6

127.1

nmol/l

0.47

173

601

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

192

698

1.91

14.98

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

187

2.86

14.97

1.4

1.5

9.0

14.5

1.87

135

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

203

753

1.87

14.91

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

570

2741

1.45

14.90

1.2

151.7

205.6

titre

0.30

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1317

7204

1.27

14.87

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

133

423

2.18

14.84

1.3

1.4

46.7

52.8

0.69

199

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

475

2205

1.50

14.84

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

319

1351

1.64

14.83

2.5

2.4

—

(3047189) Immunofixation for 24 hour Urine

309

1298

1.65

14.83

1.9

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

178

635

1.95

14.68

1.7

1.9

—

(3026480) Teichoate Ab [Titer] in Serum

253

2.55

14.64

1.1

2.4

3.0

titre

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

986

5209

1.32

14.51

2.4

2.8

398.4

6526.1

u/ml

1.55

288

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

365

1609

1.58

14.43

1.1

1607.2

1495.0

miu/ml

0.96

365

1609

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

468

2180

1.49

14.40

12.2

12.1

0.6

mmol/l

1.59

441

1995

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

124

389

2.21

14.32

1.8

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15616

102123

1.08

14.27

4.7

2.5

3.2

ug/l

3.69

14166

91825

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

343

1497

1.59

14.15

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

343

1498

1.59

14.12

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

302

1283

1.64

13.91

1.8

1.7

29.5

29.1

umol/l

0.27

287

1240

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

290

1220

1.65

13.88

2.6

138.0

148.0

au/ml

0.13

172

(3000060) B lymphocytes [#/volume] in Blood

232

918

1.76

13.87

2.0

204.9

820.9

e6/l

1.23

138

477

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1237

6779

1.27

13.79

1.2

1.3

272.0

263.2

u/ml

0.46

820

4395

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

326

1415

1.60

13.78

4.1

3.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1100

5946

1.29

13.69

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

455

2132

1.48

13.63

3.0

2.8

21.3

26.5

ug/l

0.74

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

231

930

1.73

13.04

3.3

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

231

930

1.73

13.04

3.3

2.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

436

2049

1.48

12.91

1.9

2.1

101.0

97.7

1.19

393

1917

(3027923) C peptide [Moles/volume] in Serum or Plasma

387

1779

1.51

12.76

1.6

1.2

1.3

nmol/l

0.25

300

1409

(4268621)

714

3670

1.35

12.73

2.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

937

5013

1.30

12.65

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

226

2.52

12.64

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

711

3659

1.35

12.59

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

239

2.47

12.58

2.0

1.7

48.7

45.8

umol/l

0.34

239

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

171

637

1.86

12.49

1.3

1.2

27.2

49.0

mg/l

0.32

121

466

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

745

3866

1.34

12.49

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

306

3263

0.65

12.39

1.4

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

237

978

1.68

12.27

1.8

1.7

116.8

139.4

au/ml

0.31

122

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1314

7361

1.24

12.18

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

368

1691

1.51

12.18

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

293

1279

1.59

12.17

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

132

1735

0.53

12.16

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

573

2866

1.39

12.13

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

579

2904

1.39

12.06

3.0

46.3

58.9

mg/l

0.43

410

2081

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

365

1678

1.51

12.06

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

464

2239

1.44

12.03

1.1

1.2

1.1

ratio

0.07

140

823

(3010503) CD19 cells [#/volume] in Blood

424

2012

1.46

12.00

2.7

2.5

0.2

0.3

e9/l

0.95

413

1959

(3052592) Norovirus Ag [Presence] in Stool

164

612

1.86

11.94

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

997

5425

1.28

11.85

1.6

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

402

1895

1.47

11.77

2.6

2.8

41.2

39.2

0.86

138

640

(3017569) Oxygen content in Arterial blood

309

1377

1.56

11.77

1.9

2.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

280

1220

1.59

11.74

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

101

318

2.20

11.67

1.1

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

162

2.74

11.65

1.3

1.4

1.9

1.5

0.17

108

(3036071) Salmonella sp Ab [Titer] in Serum

256

1095

1.62

11.58

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1915

11203

1.19

11.49

2.9

3.5

1480.9

1821.7

u/ml

0.16

1596

9640

(21491868) Cryoglobulin [Mass/volume] in Serum

263

1136

1.61

11.45

1.3

1.2

0.4

0.6

g/l

—

(4024509)

591

3003

1.37

11.40

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1297

7317

1.23

11.31

1.4

14.8

20.3

u/ml

0.91

143

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1428

8157

1.22

11.05

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

138

500

1.92

11.03

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

420

2024

1.44

11.02

1.6

5.3

6.6

u/l

0.92

215

971

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

401

1918

1.45

10.95

1.5

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

350

1632

1.49

10.87

1.7

1.6

1983887.7

1886803.1

iu/ml

0.06

117

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

332

1533

1.50

10.81

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

454

2228

1.42

10.79

1.8

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

341

1585

1.49

10.76

1.1

101.7

96.3

2.30

265

1270

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

298

1348

1.54

10.68

3.0

3.1

7.2

8.2

mg/l

1.93

240

1076

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

360

1696

1.47

10.64

1.1

1.2

10.8

13.0

u/ml

0.09

169

(1002224) Polysomnography panel

2502

15069

1.16

10.52

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

982

5418

1.26

10.48

1.1

10225.9

831.5

iu/ml

0.45

217

1223

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

666

6042

0.76

10.46

1.3

3.0

3.6

ug/l

1.84

570

5474

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

271

1206

1.56

10.46

2.0

1.9

152.5

165.8

1.36

252

1139

(3008037) Lactate [Moles/volume] in Venous blood

1214

6863

1.23

10.42

3.8

3.1

1.5

1.6

mmol/l

3.85

1186

6726

(3036670) Protein [Mass/volume] in Synovial fluid

214

900

1.65

10.41

1.3

1.2

40.8

40.0

g/l

0.35

114

487

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

320

1483

1.50

10.27

2.8

3.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

490

2464

1.38

10.15

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

168

668

1.75

10.04

1.0

1.3

2.1

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1106

6221

1.24

9.97

1.1

2.1

2.3

u/ml

0.13

276

1549

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

126

459

1.91

9.96

2.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

185

758

1.69

9.95

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

185

758

1.69

9.95

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

185

758

1.69

9.95

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

185

758

1.69

9.95

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

143

544

1.82

9.90

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

602

3139

1.33

9.89

4.0

4.8

164.8

98.6

u/ml

1.02

160

992

(3007463) Buprenorphine [Presence] in Urine

145

2.68

9.85

9.9

7.3

—

(3003694) ABO and Rh group [Type] in Blood

15616

103230

1.07

9.79

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

144

552

1.81

9.74

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

227

990

1.59

9.59

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

643

3404

1.31

9.53

3.5

3.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

344

1651

1.45

9.31

1.7

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1408

8173

1.20

9.30

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

183

2.43

9.27

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

259

1175

1.53

9.24

2.8

2.9

27.5

28.8

umol/l

1.13

188

897

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

287

1331

1.50

9.24

2.9

2.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

180

748

1.67

9.23

1.2

318.2

322.7

pmol/l

0.04

132

551

(3006442) Creatine [Moles/volume] in Serum or Plasma

471

2393

1.37

9.21

1.7

1.5

63.2

70.8

umol/l

2.29

185

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1367

7925

1.20

9.16

1.5

1.4

117.2

127.4

pmol/l

0.27

1321

7731

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

135

2.67

9.13

1.1

1.0

0.1

u/ml

0.03

(3008757) Leukocyte morphology finding [Identifier] in Blood

654

3499

1.30

9.00

3.4

3.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

342

1651

1.44

9.00

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

342

1651

1.44

9.00

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

342

1651

1.44

9.00

1.7

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

224

990

1.57

8.99

1.1

1.5

13.2

u/ml

0.61

125

540

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.65

8.93

1.3

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

190

811

1.63

8.81

1.4

1.3

35.6

39.3

0.60

113

562

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

405

2024

1.39

8.78

1.4

1.2

4.8

5.2

umol/l

0.85

368

1879

(3010015) Selenium [Moles/volume] in Serum or Plasma

251

2.16

8.67

2.0

1.9

1.3

umol/l

0.52

223

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

119

2.74

8.66

1.1

1.0

0.1

u/ml

0.43

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

292

1379

1.47

8.64

2.2

2.5

54.5

53.2

umol/l

0.28

230

1142

(3000093) Morphology [Interpretation] in Blood Narrative

584

3098

1.31

8.58

1.1

—

(3000012) Reticulocyte production index

349

1707

1.42

8.58

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

942

5301

1.24

8.54

1.1

3.3

2.8

u/ml

0.32

369

2666

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1181

6803

1.21

8.51

1.4

1.5

108.9

111.5

u/ml

0.36

308

1529

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

179

761

1.63

8.45

1.3

110.2

108.0

0.36

167

719

(3011048) Pyruvate [Moles/volume] in Blood

170

2.41

8.45

1.4

77.3

78.3

umol/l

0.08

156

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

140

559

1.74

8.34

2.7

2.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

129

503

1.78

8.33

1.1

2.9

6.8

pmol/l

0.58

(3028433) Virus identified in Specimen by Culture

237

1083

1.52

8.24

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

301

1444

1.45

8.24

1.9

2.0

—

(3036603) Volume of Urine

436

2231

1.36

8.22

1.6

1939.3

1943.5

0.02

527

(3032773) Endomysium IgG Ab [Titer] in Serum

560

2973

1.31

8.21

1.1

—

69.0

titre

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

249

1152

1.50

8.18

2.0

2.2

1.0

1.1

ug/l

0.17

235

1078

(3001964) Herpes simplex virus Ag [Presence] in Specimen

221

998

1.54

8.12

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

511

2683

1.32

8.11

1.8

—

(3018133) Calcium [Moles/volume] in Urine

119

457

1.81

8.09

1.8

2.6

2.7

mmol/l

0.08

102

416

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

100

365

1.90

7.97

1.9

1.7

1.8

1.7

mg/l

0.25

303

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

147

604

1.69

7.94

1.5

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

328

1.95

7.85

1.0

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

287

1379

1.45

7.82

1.5

1.4

74.4

72.7

1.37

277

1306

(21494815) CD4 cells/100 lymphocytes in Specimen

554

2958

1.30

7.82

2.2

2.1

43.6

40.6

0.97

378

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

251

1177

1.48

7.75

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

742

1.61

7.71

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5792

43275

0.92

7.69

1.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

281

1350

1.45

7.67

1.5

1.4

927.4

618.1

mu/l

0.40

271

1277

(3010370) Gastrin [Moles/volume] in Serum or Plasma

126

501

1.75

7.66

1.7

65.0

53.2

pmol/l

0.31

107

417

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

170

733

1.61

7.64

1.1

1.2

98.5

88.0

1.18

208

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

302

1472

1.42

7.63

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

302

1473

1.42

7.60

1.2

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

299

1.97

7.55

1.3

1.2

5.5

6.4

mmol/l

0.60

141

(40768800) Prostate Pathology biopsy report

713

6147

0.80

7.50

1.2

—

(3007916) DNA double strand Ab [Titer] in Serum

108

413

1.81

7.48

1.3

18.0

153.4

titre

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

225

1040

1.50

7.47

3.0

3.1

—

(3051593) INR in Capillary blood by Coagulation assay

290

1412

1.43

7.39

8.8

10.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

235

1099

1.48

7.38

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

197

2.18

7.19

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1505

8992

1.16

7.17

3.0

3.3

1.5

mg/l

1.01

1358

8308

(3016228) CD19 cells/100 cells in Blood

274

1330

1.43

7.12

2.3

2.0

7.7

8.7

0.75

266

1299

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

436

2284

1.33

7.11

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

221

2.10

7.09

2.4

3.1

14.1

401.4

pmol/l

0.65

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

167

732

1.58

7.06

1.1

1.2

73.7

77.5

0.30

200

(3014148) Varicella zoster virus Ab [Titer] in Serum

852

4850

1.22

7.02

1.1

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

138

2.41

6.98

1.5

1.6

0.2

u/l

0.11

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

271

1.97

6.88

1.6

1.9

mg/l

0.25

174

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

789

4469

1.23

6.84

1.6

1.8

3593.0

4087.0

titre

0.08

193

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

432

2277

1.32

6.77

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

267

1303

1.42

6.77

2.3

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

1108

6493

1.19

6.72

4.0

3.1

7.4

7.6

mmol/l

1.08

1082

6381

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

1.4

2.3

mg/l

1.20

188

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

2.9

1.9

mg/l

0.54

171

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

1.7

2.4

mg/l

0.61

177

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

2.3

2.6

mg/l

0.16

181

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

1.3

2.2

mg/l

1.32

155

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

0.8

1.4

mg/l

1.02

159

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

4.7

3.7

mg/l

0.50

157

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

0.7

0.9

mg/l

0.22

175

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

264

1.97

6.71

1.6

1.4

1.9

mg/l

0.62

188

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

343

1.84

6.66

2.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

181

2.18

6.65

1.0

1.1

172.0

47.6

u/l

0.53

143

(3020491) Glucose [Moles/volume] in Blood

486

2612

1.29

6.61

1.7

1.8

6.9

6.7

mmol/l

0.89

383

1913

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

416

2190

1.32

6.59

1.7

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

879

5053

1.21

6.59

1.1

5.9

4.7

u/ml

0.59

356

2104

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

380

1.79

6.56

2.5

3.2

38.6

42.8

umol/l

1.02

323

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

164

730

1.56

6.53

1.1

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

130

2.40

6.50

1.1

269.3

458.4

u/l

0.91

115

(3012565) Volume of 24 hour Urine

330

1683

1.36

6.47

2.1

2.2

1983.7

1979.1

0.03

300

1500

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

384

2011

1.33

6.33

1.4

5.7

5.6

mmol/l

0.68

350

1915

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

921

0.54

6.33

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1966

12081

1.13

6.32

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

177

808

1.52

6.31

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

753

6326

0.82

6.24

1.5

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

311

1.85

6.21

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

666

3748

1.23

6.19

1.9

29.8

23.6

ug/l

0.68

653

3670

(21494434) Karyotype in Bone marrow

480

2600

1.28

6.18

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

130

555

1.63

6.18

1.3

72.6

255.6

ng/l

0.65

359

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

117

486

1.67

6.18

1.2

1.1

—

(3003129) Base excess in Capillary blood by calculation

170

774

1.52

6.15

1.7

1.1

0.4

mmol/l

1.49

163

726

(3028679) Herpes simplex virus Ab [Presence] in Serum

383

2017

1.32

6.10

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

252

2418

0.72

6.04

1.4

29.1

31.8

nmol/l

0.82

216

2232

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

340

1.80

6.00

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

212

1017

1.45

5.96

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

758

4343

1.21

5.93

1.1

1.0

0.4

0.5

u/ml

0.14

176

893

(40761995) Spermatozoa Progressive [#/volume] in Semen

925

0.56

5.84

2.7

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

924

0.56

5.82

5.3

6.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

326

1690

1.34

5.81

1.1

18.8

26.0

u/l

2.04

250

1296

(3013247) Albumin in CSF/Albumin in Serum or Plasma

167

768

1.51

5.80

1.1

6.6

6.8

mg/g

0.24

159

729

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.59

5.76

1.1

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

202

2.03

5.75

1.0

0.2

2.0

u/ml

1.58

160

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

321

1666

1.34

5.69

1.1

7.7

9.9

u/ml

0.40

299

(3020874) Milk IgE Ab [Units/volume] in Serum

419

2258

1.29

5.66

1.1

1.0

0.4

2.9

u/ml

1.81

133

601

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

343

1.76

5.58

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

193

924

1.45

5.52

1.6

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

147

666

1.53

5.50

1.5

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

120

519

1.60

5.47

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

258

1305

1.37

5.42

1.9

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

665

3799

1.22

5.41

2.8

2.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

188

2.03

5.41

1.0

1.1

25.9

22.1

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

188

2.03

5.41

1.0

1.1

40.8

24.8

u/ml

0.46

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

510

1.61

5.40

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

352

1.73

5.39

1.3

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

225

1114

1.40

5.37

5.5

6.2

25.2

25.0

mmol/l

0.23

207

1009

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

255

2390

0.74

5.32

14.8

13.2

803.2

1248.9

nmol/l

0.55

245

2308

(40757373) Influenza virus identified in Isolate

137

616

1.54

5.32

1.7

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

274

1.82

5.21

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

182

2.02

5.17

1.4

1.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

540

3036

1.24

5.15

3.5

3.8

32.1

50.7

u/ml

3.96

530

3002

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

253

1288

1.36

5.13

1.9

2.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

321

1694

1.32

5.12

1.1

76.7

87.5

u/l

1.75

255

1349

(3037692) Legionella sp identified in Specimen by Organism specific culture

219

1089

1.40

5.12

1.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

253

1289

1.36

5.11

1.9

2.0

—

(4015189)

172

819

1.46

5.10

2.1

2.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

274

2517

0.75

5.00

18.3

18.5

1406.8

2705.5

nmol/l

1.03

258

2409

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

188

1829

0.71

5.00

1.2

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

376

1.68

4.99

1.5

1.6

122.5

109.7

ug/l

0.47

309

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

199

1.95

4.98

1.3

1.4

15.7

17.9

pmol/l

0.51

169

(3034274) Bile acid [Moles/volume] in Serum --fasting

932

5534

1.17

4.96

1.7

2.1

5.6

6.7

umol/l

1.60

651

4046

(3041672) Baker's yeast Ab [Presence] in Serum

143

2.13

4.95

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

166

791

1.46

4.92

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.38

4.91

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

912

5412

1.17

4.90

1.1

4.8

4.4

u/ml

0.15

353

2129

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

408

2236

1.27

4.90

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

781

4586

1.18

4.78

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

181

883

1.42

4.75

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

208

1040

1.39

4.75

2.3

1.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

293

1.75

4.74

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1002

6014

1.16

4.67

1.4

1.5

0.3

0.4

nmol/l

2.73

746

4802

(3015183) Erythrocyte sedimentation rate

347

1877

1.28

4.65

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

780

4595

1.18

4.61

2.4

2.7

250.2

807.8

u/ml

1.19

751

4361

(3051651) Icteric interference index of Serum or Plasma

365

1990

1.27

4.60

3.7

3.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

362

1974

1.27

4.56

1.1

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

284

1500

1.31

4.56

29.4

27.4

115.6

116.9

ug/l

0.13

243

1235

(3044009) aPTT.lupus sensitive (LA screen)

328

1.69

4.56

1.2

—

(4146454)

589

3389

1.21

4.54

2.7

2.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

329

1.69

4.51

1.1

1.8

2.8

umol/24h

0.43

329

(1761482) Bacteria [#/volume] in Urine by Culture

1340

8229

1.13

4.49

5.1

3.9

—

(3006462) Nitrate [Presence] in Urine

306

1637

1.30

4.48

2.7

3.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

404

1.61

4.48

2.1

2.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

122

558

1.52

4.46

1.3

83.7

168.5

titre

0.45

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

248

1.79

4.43

1.1

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

223

1.84

4.42

1.2

1.1

18.5

14.7

nmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

104

460

1.57

4.41

1.1

1.2

—

(3019174) dRVVT (LA screen)

316

1.69

4.39

1.1

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

173

852

1.41

4.35

2.2

1.9

35.9

37.9

u/l

0.06

160

763

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

317

1.69

4.34

1.1

—

(40762814) Titanium [Mass/volume] in Blood

109

491

1.54

4.29

2.3

3.1

3.8

ug/l

1.13

173

(37021550) Renin [Units/volume] in Plasma --upright

142

677

1.46

4.26

1.3

51.2

80.4

mu/l

1.13

517

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

168

830

1.40

4.17

1.2

1.1

—

(4211845)

329

1799

1.27

4.10

2.7

3.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5897

38799

1.06

4.09

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

127

1269

0.69

4.04

1.0

—

(3017509) Phencyclidine [Presence] in Urine

443

1.55

4.03

2.1

1.8

—

(3034426) Prothrombin time (PT)

228

1190

1.33

4.03

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

133

634

1.46

4.02

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.31

3.99

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

489

2806

1.21

3.94

1.2

368.3

369.7

nmol/l

0.06

424

2366

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

232

1.76

3.94

1.1

7.1

10.4

u/l

0.95

232

(3037556) Urate [Mass/volume] in Serum or Plasma

175

883

1.38

3.87

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

603

3535

1.18

3.86

1.3

1.4

11.6

11.9

mmol/l

0.22

157

792

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

367

1.59

3.81

1.0

0.0

0.2

u/ml

2.89

223

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.37

3.79

1.7

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

185

1.84

3.74

1.0

1.1

2.8

u/l

—

(40768441) Liver Pathology biopsy report

426

2426

1.22

3.73

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

176

1.85

3.69

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

394

2229

1.23

3.69

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

152

1.92

3.65

1.3

1.5

1.7

mg/l

0.48

126

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

108

505

1.48

3.64

1.0

83.6

80.9

ug/l

0.23

416

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

187

1.82

3.63

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

109

512

1.48

3.60

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

148

1.92

3.59

1.0

1.2

0.3

0.7

umol/24h

1.15

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

855

5183

1.15

3.58

1.3

7.1

7.0

mmol/l

0.28

637

3683

(40761539) Cells [Type] in Urine sediment by Light microscopy

167

850

1.36

3.54

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

120

2.02

3.54

1.4

393.0

527.0

nmol/l

0.91

120

(3036048) Francisella tularensis Ab [Titer] in Serum

156

786

1.38

3.52

1.2

271.1

520.0

titre

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

311

1.61

3.46

1.0

0.0

1.2

u/ml

1.59

231

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

455

1.49

3.44

2.9

3.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.64

3.43

1.1

—

(3022689) Creatine [Moles/volume] in Urine

178

921

1.34

3.41

1.4

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

186

1.79

3.41

1.3

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

212

1.73

3.39

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

139

694

1.39

3.34

2.4

2.6

—

(3045142) Bone marrow Pathology biopsy report

571

3380

1.17

3.32

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

272

1.63

3.30

1.4

1.3

5.4

14.8

pmol/l

3.63

229

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1954

12463

1.09

3.30

1.5

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2760

20508

0.93

3.30

1.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

235

1.68

3.29

1.1

1.2

27.7

22.5

0.21

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

432

1.49

3.28

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

449

1.48

3.27

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

270

1489

1.26

3.24

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.48

3.22

1.1

91.2

104.6

nmol/24h

0.46

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

391

2246

1.21

3.21

1.5

1.4

12.9

12.6

u/l

0.37

375

2172

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

463

1.47

3.19

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

221

1192

1.29

3.18

1.6

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

165

1.81

3.18

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

313

1.57

3.17

1.0

0.1

0.6

u/ml

2.31

177

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

211

1132

1.29

3.16

2.1

1.6

68448.7

15294.7

u/ml

0.59

139

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.39

3.14

1.8

2.4

1.3

2.4

mu/l

1.50

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

100

477

1.45

3.11

1.7

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

870

5339

1.13

3.09

1.9

2.1

2.7

7.5

titre

2.49

155

(3007542) Rye IgE Ab [Units/volume] in Serum

182

1.75

3.09

1.1

1.0

0.2

10.6

u/ml

0.52

(3042628) Porphyrins [Moles/volume] in Urine

5.55

3.07

1.1

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.81

3.05

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

367

1.51

3.02

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

318

1.55

2.99

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

258

1431

1.25

2.98

3.2

5.1

1548.2

2704.8

mg/l

0.47

187

1013

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

346

1.52

2.98

1.0

0.1

1.7

u/ml

0.84

184

(3014599) Egg white IgE Ab [Units/volume] in Serum

386

2234

1.20

2.96

1.0

1.8

2.2

u/ml

0.11

102

512

(3005011) Chlamydia sp Ab [Titer] in Serum

477

1.44

2.94

1.5

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

398

1.48

2.92

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

357

2055

1.21

2.91

5.8

6.7

—

(3020618) Glucose [Moles/volume] in Synovial fluid

106

1.96

2.85

1.0

1.1

4.9

5.4

mmol/l

0.41

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

106

1.96

2.85

1.0

1.1

0.2

g/l

0.19

(3025130) Human papilloma virus identified in Specimen

863

5325

1.13

2.84

1.8

1.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

103

504

1.42

2.83

1.1

0.2

0.3

u/ml

0.39

309

(3050794) Legionella sp Ab [Presence] in Serum

284

1.56

2.82

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

307

1.54

2.79

1.2

49.3

47.3

mg/l

0.12

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

334

0.52

2.77

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

121

612

1.37

2.76

1.4

1.9

2.9

3.4

ug/l

0.19

378

(3042301) Urate [Moles/volume] in Synovial fluid

2.31

2.69

1.0

363.9

357.2

umol/l

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

2.70

2.67

1.0

0.1

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

339

1.49

2.65

1.0

0.1

0.3

u/ml

0.94

187

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

511

3062

1.16

2.63

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

466

1.41

2.61

2.2

2.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

114

579

1.37

2.56

1.0

1.1

0.4

3.3

u/ml

2.07

412

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

146

770

1.32

2.56

1.2

1.3

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

199

1.64

2.54

1.1

1.0

5.6

22.5

u/ml

4.54

161

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

270

1.54

2.53

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

959

6011

1.11

2.44

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

123

1.80

2.42

20.9

15.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

229

1.58

2.42

2.9

2.2

—

(3034614) HLA Ag [Interpretation]

2.06

2.42

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

958

6009

1.11

2.41

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

235

1.56

2.40

3.0

2.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

289

2400

0.83

2.40

1.2

1.3

1.4

1.5

g/l

0.44

134

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

113

581

1.35

2.38

2.3

5.2

69.8

54.3

u/l

0.20

240

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

400

2376

1.17

2.36

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

436

1.40

2.33

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

461

1.38

2.29

1.2

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.70

2.27

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.07

2.23

1.6

1.4

2.5

2.1

mmol/24h

0.37

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

438

3490

0.87

2.20

1.6

8.1

7.5

mmol/l

3.32

286

2046

(3011897) Casein IgE Ab [Units/volume] in Serum

106

548

1.34

2.19

1.1

1.2

0.1

8.7

u/ml

1.52

124

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

337

1.44

2.19

3.0

2.4

0.9

1.2

mmol/l

0.77

240

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

378

1.41

2.17

1.1

—

(36303858) Crystals [Presence] in Urine

2.31

2.16

1.1

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.00

2.15

1.0

1.1

0.4

0.1

g/l

—

(3018001) Oat IgE Ab [Units/volume] in Serum

242

1.52

2.14

1.0

0.2

1.0

u/ml

0.71

(3026692) Albumin [Mass/volume] in Peritoneal fluid

142

768

1.28

2.13

1.5

1.4

12.3

13.7

g/l

0.89

596

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

226

1.53

2.12

5.1

4.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

475

1.36

2.09

1.2

1.3

—

24.3

—

(3024316) Viscosity of Plasma

156

1.65

2.08

1.2

1.9

1.6

mpas

0.11

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

415

2501

1.15

2.07

1.4

12.8

12.0

umol/l

1.38

394

2375

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

195

1.57

2.04

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

118

627

1.31

2.04

1.8

2.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

141

1.67

2.04

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.26

2.03

1.3

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

163

1.62

2.01

1.1

1.0

0.1

8.9

u/ml

0.54

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

390

1.39

2.01

7.3

7.7

0.3

0.4

umol/l

0.99

350

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.37

1.98

1.0

1.2

—

(3035880) pH of Pleural fluid

280

1643

1.18

1.98

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

393

0.64

1.98

4.7

7.4

—

(3013466) aPTT in Blood by Coagulation assay

220

1.51

1.94

1.0

1.1

34.9

37.2

2.06

190

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

173

971

1.24

1.94

1.8

1.9

9736.1

12012.4

e6/l

0.23

513

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

141

773

1.27

1.94

10.1

8.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

200

1140

1.22

1.94

1.1

1.0

8.4

10.8

u/ml

0.35

161

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

126

682

1.28

1.92

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

204

1.53

1.91

1.1

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

101

531

1.32

1.91

2.7

3.1

15.3

14.7

ml/dl

1.37

494

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

126

683

1.28

1.90

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

1.97

1.89

1.1

1.0

65.4

55.4

mu/l

0.09

(3027035) Albumin [Mass/time] in 24 hour Urine

307

1.42

1.89

1.3

186.6

366.4

mg/24h

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

126

684

1.28

1.88

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

250

1.47

1.88

1.2

87.3

109.3

ug/l

0.71

148

(3038071) Oxygen [Partial pressure] in Mixed venous blood

124

672

1.28

1.88

10.3

8.6

—

(44806071)

479

1.33

1.86

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

576

0.71

1.85

4.1

5.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

320

1.41

1.85

2.0

2.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.38

1.85

1.0

—

(4133840)

176

996

1.23

1.84

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

206

1.52

1.84

1.0

1.1

0.3

1.1

u/ml

1.14

142

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.79

1.83

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

135

1.64

1.83

9.4

9.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

585

3641

1.12

1.80

1.5

4256.3

3154.2

e6/l

0.52

443

2621

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.25

1.80

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.25

1.80

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.25

1.80

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.25

1.80

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.25

1.80

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.25

1.80

1.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

145

808

1.25

1.77

1.3

1.4

26.0

21.2

1.13

136

724

(1617658) Protocol used for examination of sentinel lymph nodes

309

2477

0.86

1.76

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.16

1.76

1.0

1.1

1363.6

2135.3

titre

0.88

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

297

2384

0.86

1.73

1.7

1.8

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

116

1.67

1.72

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.02

1.72

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.20

1.71

1.4

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

115

0.42

1.71

1.4

2.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.92

1.70

1.1

1.0

3.4

0.4

u/ml

0.55

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

107

578

1.28

1.70

1.5

1.4

4.9

6.6

nmol/l

1.54

100

554

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

184

1057

1.21

1.69

1.4

58.1

62.5

0.89

154

860

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

192

1593

0.84

1.69

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

185

1065

1.21

1.67

3.2

3.5

53.8

52.8

0.26

179

1027

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

178

1.52

1.65

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

337

2041

1.15

1.65

1.0

0.4

0.7

u/ml

0.57

281

(3001729) Color of Synovial fluid

252

1.43

1.65

1.4

1.7

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.89

1.64

1.3

1.5

177.2

131.7

nmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

502

1.30

1.64

1.3

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

173

1.52

1.63

1.5

1.7

0.9

0.7

umol/l

1.07

132

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

533

1.29

1.62

1.3

1.4

0.3

nmol/l

0.05

384

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

3.85

1.62

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

121

0.46

1.62

1.4

2.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

313

1889

1.15

1.61

1.8

1.7

1.8

2.4

u/field

1.07

223

1358

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.31

1.61

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

155

882

1.22

1.59

1.1

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

119

659

1.25

1.57

5.3

6.2

66.6

70.8

0.93

520

(21494567) Legionella sp IgM Ab [Presence] in Serum

238

1.43

1.55

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

109

599

1.26

1.54

1.1

—

(44806420)

145

823

1.22

1.54

2.2

2.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

170

1.51

1.53

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

174

1006

1.20

1.53

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.87

1.51

1.1

2.4

2.5

0.07

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.70

1.51

1.1

1.2

37.4

26.3

nmol/24h

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.70

1.51

1.0

1.1

12.6

17.8

umol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

228

1.43

1.50

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

205

1.45

1.50

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.71

1.50

1.0

0.1

u/ml

0.25

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

234

1.42

1.50

7.3

5.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

3.47

1.49

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

217

1.44

1.49

1.5

1.4

415.7

307.9

umol/24h

1.33

217

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

200

1.46

1.48

1.1

—

(3048879) Bone marrow aspiration report

155

892

1.21

1.45

1.5

1.9

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

156

1.51

1.44

1.0

1.4

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

123

1.58

1.42

1.0

0.6

0.2

u/ml

0.38

(4281824)

467

3589

0.90

1.42

1.2

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.76

1.41

1.3

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.78

1.40

1.0

1.1

0.0

0.1

g/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

441

1.29

1.40

1.3

2.2

1.2

mmol/l

0.64

279

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

113

1.60

1.38

1.0

144.9

225.0

pmol/l

1.13

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

345

1.33

1.38

3.4

2.9

1.5

1.3

mg/l

0.32

233

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

380

2354

1.12

1.36

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.12

1.35

1.0

1.1

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.96

1.33

1.0

0.1

0.2

u/ml

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.69

1.32

1.0

0.7

0.6

u/ml

0.11

(3012898) Urea [Moles/volume] in Urine

348

1.32

1.3

1.6

177.5

168.0

mmol/l

0.27

311

(3002331) Protein [Mass/volume] in Peritoneal fluid

121

688

1.22

1.31

1.3

1.4

37.6

34.9

g/l

0.07

535

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

2.41

1.30

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

2.89

1.27

1.0

1.1

0.0

3.7

u/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

186

1104

1.17

1.27

1.9

2.0

3621.2

3315.3

e6/l

0.04

128

746

(3027974) Hepatitis B virus e Ag [Presence] in Serum

219

1.39

1.27

1.6

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

231

1.38

1.26

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

388

1.29

1.24

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

358

1.30

1.23

1.4

69.3

71.8

0.27

303

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

438

1.27

1.22

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

310

1.32

1.22

1.5

1.6

—

(3044007) Cell count panel - Peritoneal fluid

150

880

1.18

1.19

1.9

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.63

1.18

1.5

1.6

162.3

114.0

ug/l

0.34

(3026250) Tacrolimus [Mass/volume] in Blood

257

1572

1.13

1.18

36.0

36.2

7.6

7.3

ug/l

0.96

227

1438

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.13

1.17

1.0

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.76

1.16

1.5

1.4

0.7

0.6

u/field

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.04

1.14

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

320

1.30

1.14

1.0

0.0

1.5

u/ml

1.39

232

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

437

1.25

1.13

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.58

1.12

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

544

1.22

1.11

1.2

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

455

2884

1.09

1.11

1.4

1.3

6.5

6.3

mmol/l

0.72

418

2670

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

202

1.37

1.09

1.1

3.8

9.1

u/ml

2.29

148

(3007919) Fasciola sp Ab [Titer] in Serum

1.77

1.09

1.1

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

509

1.23

1.07

2.5

2.8

2331.8

1622.1

u/l

0.23

457

(3045788) Cell count panel - Pleural fluid

442

2804

1.09

1.07

1.5

—

(40759632) Porphyrins [Mass/mass] in Stool

1.98

1.07

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.98

1.07

1.1

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

203

1.37

1.06

1.1

1.0

1.2

u/field

1.56

141

(3028308) Erythrocytes [#/volume] in Pleural fluid

518

3310

1.09

1.06

1.5

46403.9

56025.8

e6/l

0.47

327

1966

(4212803)

269

1.32

1.06

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

154

917

1.17

1.06

1.3

3.6

3.5

mmol/l

0.16

137

843

(3003434) Protein [Mass/volume] in Pleural fluid

629

4054

1.08

1.05

1.5

32.2

33.2

g/l

1.15

563

3649

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

198

1.37

1.04

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

111

644

1.20

1.04

2.3

2.5

7.3

7.4

mmol/l

0.05

389

(3034092) Cytoplasmic Ig cells/100 cells in Blood

474

1.23

1.03

9.3

7.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.11

1.03

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.31

1.01

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

176

1.38

1.00

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.54

0.98

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

136

1.43

0.97

1.0

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

231

1.32

0.97

1.0

0.4

0.6

u/ml

0.51

131

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

373

1.25

0.95

2.8

2.5

23.7

22.7

mg/l

0.24

353

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

432

2757

1.09

0.95

1.3

460.5

495.1

u/l

0.21

405

2611

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.94

0.95

1.6

2.8

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

238

1.31

0.95

1.1

1.0

0.0

0.7

u/ml

0.92

154

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

100

581

1.19

0.94

2.7

2.5

37.4

52.8

mg/l

0.54

(3017958) Strawberry IgE Ab [Units/volume] in Serum

108

1.48

0.94

1.0

0.0

0.2

u/ml

1.14

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

257

1.30

0.93

1.0

1.1

4.0

19.8

iu/ml

3.20

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

115

1.45

0.90

1.0

0.3

0.1

u/ml

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8364

58974

0.98

0.89

2.8

2.9

0.7

0.8

ug/l

12.81

5508

37662

(3004446) Plasmodium sp identified in Blood by Light microscopy

402

1.23

0.88

2.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

517

1.19

0.86

5.6

5.0

51.4

45.0

ug/min

0.37

401

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

122

1.42

0.86

1.0

0.6

0.4

u/ml

0.18

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

188

1.33

0.84

1.2

2.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

111

1.44

0.84

1.0

0.8

0.9

u/ml

0.04

(40768793) Breast Pathology biopsy report

1131

7489

1.05

0.83

1.3

—

(3045177) Copper [Moles/volume] in Urine

1.64

0.82

1.1

0.1

0.5

umol/l

—

(4035726)

4278

29015

1.02

0.79

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

107

1.43

0.78

1.1

—

(3033799) Differential panel - Peritoneal fluid

156

956

1.13

0.78

2.2

1.8

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

185

1.31

0.77

1.2

1.3

2147.7

786.4

u/l

0.38

164

(3042733) HLA Ab [Presence] in Serum

196

1220

1.11

0.77

5.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

378

1.21

0.76

1.3

592.9

166.7

u/l

0.35

274

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.17

0.76

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.17

0.76

1.2

1.1

—

(36304079) Mucus [Presence] in Urine sediment

2.17

0.76

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

493

1.18

0.75

1.3

1.4

7.0

242650.8

nmol/l

2.77

401

(3041184) Isoniazid [Presence] in Urine

1.69

0.75

2.9

2.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.87

0.74

1.4

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

217

1.28

0.74

1.6

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

120

726

1.15

0.74

1.5

1.4

22.4

23.0

0.08

606

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

2.04

0.73

1.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

218

1.27

0.72

1.5

1.7

0.7

0.12

171

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.54

0.72

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.69

0.71

1.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

231

1.26

0.71

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

152

0.68

0.71

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.42

0.70

1.1

—

mmol/l

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.42

0.70

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

1.93

0.70

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

1.93

0.70

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

427

1.19

0.70

2.4

2.5

0.7

0.6

u/field

0.38

427

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.52

0.68

2.0

2.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

366

1.19

0.66

2.9

2.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.46

0.66

6.2

5.2

0.4

0.2

mmol/l

0.93

(3029396) Erythrocyte agglutination [Presence] in Blood

163

1254

0.90

0.64

2.8

3.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

270

1728

1.08

0.63

4.9

6.2

386.8

3210.5

u/ml

0.91

360

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

180

0.73

0.63

9.9

10.2

128.9

311.1

e6/l

0.94

133

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

180

1131

1.10

0.63

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.54

0.62

1.0

10012.8

11440.4

ng/l

—

(3009677) Dengue virus Ab [Presence] in Serum

149

1.30

0.62

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

131

0.69

0.61

2.3

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

288

1.20

0.59

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

200

1269

1.09

0.59

2.2

2.5

132.0

152.9

nmol/l

2.31

174

1104

(3013762) Body weight Measured

144

0.72

0.56

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

145

910

1.11

0.55

1.3

1.4

3.3

2.6

0.31

124

760

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

171

1.26

0.55

1.0

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

134

1.29

0.54

1.1

0.9

1.2

u/field

0.57

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

234

1502

1.08

0.54

1.1

1.2

—

(3001556) Androgen free Index in Serum or Plasma

420

1.16

0.54

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

1.43

0.53

1.1

1.2

—

(3024932) HLA-DR beta [Type]

185

1177

1.09

0.53

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.45

0.53

2.8

2.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

467

1.14

0.52

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2041

13817

1.03

0.51

1.6

4.1

3.4

mg/l

1.81

1513

9533

(3035933) Granulocytes/100 leukocytes in Blood

152

962

1.10

0.50

1.4

1.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

224

1442

1.08

0.50

1.1

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

136

1.27

0.50

2.1

1.7

19.1

20.2

mmol/l

0.09

110

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

323

0.84

0.48

1.1

26.1

20.0

u/l

0.53

218

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

108

0.71

0.48

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.39

0.47

1.0

1.1

—

(3024471) HLA-A [Type]

188

1206

1.08

0.47

1.0

—

(3022670) pH of Venous cord blood

1.44

0.44

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

724

0.90

0.44

1.7

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

255

1661

1.06

0.43

1.6

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

396

1.14

0.43

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.46

0.43

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

183

0.80

0.43

3.3

3.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

267

1.17

0.42

1.1

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.58

0.42

1.8

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

515

1.12

0.42

6.5

7.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.32

0.42

1.1

1.0

0.0

0.2

u/ml

—

(3004775) Volume in Urine collected for unspecified duration

397

2625

1.05

0.41

2.3

670.2

677.7

0.12

270

1800

(46235168) Fasting glucose [Moles/volume] in Blood

435

0.88

0.40

1.8

6.9

7.2

mmol/l

0.26

165

(3041918) Cholesterol [Moles/volume] in Pleural fluid

563

1.11

0.40

1.3

1.2

1.9

1.7

mmol/l

0.54

346

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

275

1.16

0.40

2.0

2.2

2.8

3.2

mg/l

0.54

264

(3049242) von Willebrand panel - Platelet poor plasma

110

1.26

0.39

1.8

1.6

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.39

0.38

1.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

103

0.74

0.38

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

142

1.22

0.38

1.2

1.3

1.4

1.0

u/field

0.79

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.28

0.37

2.1

3.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.49

0.36

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.30

0.33

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

605

4063

1.03

0.33

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.32

0.32

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

262

1.14

0.32

1.7

3.2

2.4

2.2

mg/l

0.29

226

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

272

0.87

0.32

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

331

2200

1.04

0.31

1.3

13.2

14.0

u/l

0.32

302

2033

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

217

1.15

0.31

3.5

2.0

10.5

17.0

0.48

109

(3016750) Collection duration of Urine

296

1965

1.04

0.30

2.3

2.2

490.5

502.4

min

1.23

215

1465

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

192

1.16

0.29

1.0

—

(3025315) Body weight

298

1.12

0.28

5.3

4.4

—

(3020650) Glucose [Presence] in Urine

151

988

1.06

0.27

1.5

1.4

—

(40758292) HTLV I+II Ab panel - Serum

578

1.08

0.27

1.3

1.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

273

1.12

0.26

3.5

2.0

56.4

59.0

0.13

167

(3013336) Amino acids [Identifier] in Serum or Plasma

1.25

0.26

2.1

3.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.20

0.25

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

282

1.11

0.23

1.2

1.4

1.1

1.5

ml/s/173m2

0.60

181

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

118

1.18

0.23

1.2

1.1

280.3

251.8

nmol/l

0.25

118

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

597

1.07

0.23

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

642

4352

1.02

0.22

2.3

2.5

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.22

0.0

2.6

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.19

0.21

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

190

0.88

0.21

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

101

0.82

0.21

3.9

6.0

1.8

1.2

mg/l

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

205

1.12

0.20

1.5

1.4

23.2

22.4

mmol/l

0.51

131

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.20

0.0

1.2

—

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

340

2429

0.97

0.20

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

133

1.15

0.20

1.2

—

(3027874) Urate [Moles/volume] in Urine

107

1.17

0.20

1.1

2.2

7.3

mmol/l

—

(3003577) Lead [Moles/volume] in Blood

279

1.09

0.19

1.3

1.4

0.2

umol/l

0.49

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

405

2882

0.97

0.19

1.5

1.3

141.1

101.6

pmol/l

0.24

140

933

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

225

1506

1.04

0.19

1.2

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.23

0.19

1.2

1.0

—

(4038314)

267

0.91

0.18

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

207

1.11

0.18

4.1

2.5

23.3

16.4

0.60

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.21

0.18

1.0

0.0

0.1

u/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

387

2751

0.98

0.18

2.0

2.5

2.3

u/field

0.25

194

1194

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.84

0.16

7.7

9.0

—

(3018291) Platelet Ab [Presence] in Serum

1.10

0.15

1.1

—

(40768446) Kidney Pathology biopsy report

201

1435

0.97

0.14

1.7

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

454

1.05

0.13

2.0

2.7

52.7

73.6

pmol/l

1.07

392

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.87

0.11

7.5

8.7

30.8

45.2

—

(40768795) Lymph node Pathology biopsy report

468

3293

0.99

0.10

1.2

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.13

0.10

4.3

5.1

9.9

4.4

mg/l

—

(3006598) pH of Arterial cord blood

1.16

0.09

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

617

0.97

0.09

4.8

5.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

283

1.05

0.09

1.1

16.7

17.4

g/l

0.27

257

(3051387) C reactive protein [Mass/volume] in Capillary blood

1058

7397

0.99

0.09

4.3

3.2

23.1

27.1

mg/l

3.51

657

4643

(3021374) Sirolimus [Mass/volume] in Blood

1.10

0.09

5.8

10.0

6.8

7.6

ug/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

311

1.05

0.08

1.3

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

207

0.94

0.08

3.4

5.5

—

(40768806) Pleura Pathology biopsy report

451

3166

0.99

0.08

1.5

—

(3044316) Mercury [Moles/volume] in Urine

0.83

0.08

3.2

2.4

13.7

11.2

nmol/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

157

0.93

0.08

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.82

0.08

1.3

3.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

176

1.06

0.07

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

252

1721

1.02

0.07

1.2

1.3

—

(3022475) Manganese [Moles/volume] in Blood

220

0.95

0.07

1.2

1.3

—

(3014891) Appearance of Pleural fluid

424

0.96

0.07

1.7

1.6

—

(3012441) Differential panel - Pleural fluid

462

3171

1.01

0.07

1.5

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.12

0.06

1.0

1.1

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.12

0.06

1.0

1.1

—

358.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

248

1.03

0.04

1.1

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

118

1.06

0.03

2.2

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

121

828

1.01

0.03

1.2

1.3

289.3

263.5

ug/l

0.04

452

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

229

0.97

0.03

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

277

1.03

0.03

3.4

4.3

53.2

48.9

g/mol

0.06

256

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

106

727

1.01

0.02

2.7

2.6

113.9

97.8

ng/l

0.30

359

(3013862) HLA-DP [Type]

130

0.96

0.01

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.94

0.01

1.3

1.2

—

(40760409) HLA-A [Type] by High resolution

127

1.04

0.01

1.0

—

(40760410) HLA-B [Type] by High resolution

127

1.04

0.01

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

143

0.97

0.00

1.1

1.2

0.1

g/l

0.61

103

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

115

0.96

0.00

1.1

1.2

1190.5

4176.7

ng/l

—

(3029612) Listeria sp Ab [Titer] in Serum

1.03

0.00

1.5

1.3

—

(46236302) HLA-C [Type] by High resolution typing

128

1.03

0.00

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

188

1.00

0.00

1.1

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

113

0.98

0.00

1.0

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

380

1.00

0.00

1.2

1.3

24.3

24.7

0.03

296

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

128

0.98

0.00

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

459

1.00

0.00

1.3

1.4

11.7

11.4

0.03

232

(3003157) Bacteria [#/volume] in Mother's milk

0.95

0.00

4.3

6.9

—

(40758358) Immune stain study

147

0.99

0.00

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

755

5232

1.00

0.00

3.7

3.5

31.3

38.4

u/ml

1.15

733

5034

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.02

0.00

1.0

1.4

154.6

45.3

e6/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

139

1.00

0.00

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.98

0.00

1.1

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.00

0.00

1.0

200.8

327.4

u/l

0.49

(40763590) HLA-DQ beta [Type]

127

0.98

0.00

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.01

0.00

1.5

1.3

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.01

0.00

1.5

1.3

—

(3035060) Mercury [Moles/volume] in Blood

1.01

0.00

1.6

1.7

9.1

12.4

nmol/l

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.99

0.00

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.85

0.00

1.2

2.8

35.6

34.6

umol/l

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.97

0.00

1.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

0.0

1.0

—

12.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.95

0.00

1.0

1.1

131.6

142.9

mmol/24h

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

1.01

0.00

1.0

—

0.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_LOWBACKPAINORANDSCIATICA and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_LOWBACKPAINORANDSCIATICA	1.231 [1.12, 1.35]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.626

During the follow-up period (1.1.1998 — 31.12.2019), 25357 out of 199500 females with M13_LOWBACKPAINORANDSCIATICA died.

Males

Parameter	HR [95% CI]	p-value
M13_LOWBACKPAINORANDSCIATICA	1.367 [1.24, 1.51]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 19820 out of 144981 males with M13_LOWBACKPAINORANDSCIATICA died.

Mortality risk

Mortality risk for people of age

years, who have M13_LOWBACKPAINORANDSCIATICA.

N-year risk	Females	Males
1	0.106%	0.226%
5	0.798%	1.378%
10	1.846%	3.6%
15	3.633%	6.599%
20	6.298%	11.051%

Relationships between endpoints

↥

Index endpoint: M13_LOWBACKPAINORANDSCIATICA – Lower back pain or/and sciatica

GWS hits: 12

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lower back pain or/and sciatica

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints